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 Research involving caffeinated energy drinks and endurance cycling protocols is 
limited.  Many studies have been conducted consisting of sprint trials and shorter duration 
protocols.  Understanding the interaction the human body has with energy drinks is important 
to contribute to the existing body of literature and discover benefits from these supplements.  
The purpose of this study was to determine the effect two doses of a caffeinated energy drink 
(70 mg or 140 mg), or placebo have on performance time, rating of perceived exertion 
(RPE), heart rate (HR), respiratory exchange ratio (RER) and volume of oxygen consumption 
(VO2) for a cycling bout of 10 miles.  The researcher utilized 16 recreationally experienced 
male cyclists that were caffeine naïve, and aged 18-60, for this study. Following pre-
screening, subjects met for 3 separate 10-mile cycling trials, each time ingesting a different 
dose/type of drink as randomized by the researcher.  Sample sizes ranged from 13-16 due to 
missing observations in data and 1 subject not completing the trials.  Subjects ingested the 
randomized drink upon arrival and waited for 20 minutes before starting their 5 minute 
warm-up on the stationary ergometer.  Rating of perceived exertion, RER, HR, and VO2, 
were reported in 2 mile increments, with performance time being reported once. For the 
variables RPE, VO2, and HR the means between distances (2, 4, 6, 8, & 10 miles) were 
significantly different (p < .001) within each dose.  For RER, only the control group means 
were significantly different (p = .009) from 2-4-6-8-10 miles.  For the variables RPE, RER, 
and HR the means between doses were not significantly different.  For VO2, only at 2 miles 
were the Control means between doses significantly different (p = .033).  Effect size was 
highly correlated with the p-values (r = -0.789, p < .001) for all variables.  The researcher 
concluded that no confident explanation of unanticipated significant findings could be 
declared, and the null hypothesis was accepted. Future research should include a higher dose 
of caffeine, and also utilize a homogenous, competitive group of cyclists as determined by 
fitness level, BMI, experience, and type of cycling.  Familiarization trials should be utilized 























 Caffeine has been widely studied for years in many different contexts.  Unlike 
previous research, the current study utilized a longer distance in the cycling protocol. This 
study employed recreational cyclists and a popular energy drink to explore the potential 
performance enhancing effects of the substance.  Energy drinks are not regulated by the Food 
and Drug Administration (FDA), therefore there is a need to further study their potential 
effects.  Most researchers only look at the effect of caffeine covering a short distance or a 
specific period of time (Wiles, Coleman, Tegerdine, & Swaine, 2006), or in doses based on 
body weight, such as 5 mg/kg body weight (Astorino, Cottrell, Lozano, Aburto-Pratt, & 
Duhon, 2012).  The key to making this study unique is the distance the cyclists traveled after 
consuming an energy drink in typical quantities.  Sprint tests and 1 km laboratory tests are 
frequently conducted (Wiles et al., 2006); however, there have not been many studies 
covering longer distances.   
The importance of the current study was to determine if caffeine ingested as a popular 
energy drink impacted cycling performance while cycling 10 miles on an indoor cycle 
ergometer.  The caffeine load, 70 mg or 140 mg, was chosen to represent a medium and high 
dose.  The full can of the energy drink contains 140 mg of caffeine; therefore, half a can 
equals 70 mg of caffeine. Also, utilizing a popular energy drink was important to determine 
its effectiveness on performance. The researcher was interested in seeing if typical 
consumption (½ to 1 can) impacted actual performance in caffeine naïve subjects. Doses 
were administered to subjects 20 minutes before the trial began, since caffeine has been 
shown to peak within the bloodstream 35-45 minutes after ingestion (Liguori, Hughes, & 
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Grass, 1997).  Oxygen uptake (VO2) and respiratory exchange ratio (RER) were measured 
utilizing the OxyCon portable VO2 analyzer, manufactured by Care Fusion™; and the values 
were recorded every 2 miles during the 10 mile cycling distance.  Rating of perceived 
exertion (RPE) and heart rate (HR) were also recorded every 2 miles, and completion time of 
the 10 mile distance was recorded at the end of each trial.  
Background 
Caffeine is consumed by over 85% of Americans on a daily basis (Liguori et al., 
1997). Caffeine can be found in many forms including: coffee, tea, sports drinks, pills, pre-
workout powders, and energy drinks.  Caffeine is an ergogenic aid that can potentially 
enhance performance with cycling (Astorino et al., 2012).  This drug affects users in different 
ways. People who are sensitive to caffeine may experience anxiety, jittery behavior, 
restlessness, or even gastrointestinal issues.  The Food and Drug Administration (FDA), as 
discussed by the Mayo Clinic, states that a heavy dose of caffeine is 500-600 mg per day 
(Spriet & Graham, 2013).  The average cup of coffee contains 100-120 mg of caffeine; 
therefore reaching the heavy dose would only take about 4 cups of coffee (Spriet & Graham, 
2013).  The National Collegiate Athletic Association (NCAA) and the International Olympic 
Committee (IOC) have certain limits on caffeine for athletes in sport and anything above this 
limit will result in the athlete being banned from competition. For the IOC, the upper limit 
for caffeine consumption is 12 micrograms (µg)/ml and for the NCAA the upper limit is 
15µg/ml (Spriet & Graham, 2013).  One microgram equates to 0.001 milligrams.  These 
limits are in existence because caffeine could potentially give athletes an unfair advantage on 




 Dosages of caffeine studied have varied from 1 mg/kg to upwards of 10 mg/kg 
(Astorino et al., 2012 ; Ivy et al., 2009).  It was important to conduct the current study to see 
how two typical doses of caffeine in the form of an energy drink affected cycling 10 miles 
using an indoor cycling ergometer. Del Coso et al. (2012) stated that caffeine is the most 
often ingested type of legal drug in the world and is widely available in many forms, 
including food.  “In the sports setting, caffeine is consumed prior to competing by 74% of 
elite national and international athletes, based on the caffeine concentration found in the 
urine samples obtained for doping analysis” (Del Coso et al., p.1, 2012).   
The doses utilized in the present study, 70 mg or 140 mg caffeine, would amount to 
.09 – 1.86 mg/kg body weight in an average weight rider of 75 kg.  This is not a very large 
dose compared to the use of caffeine at 6 mg/kg utilized by Irwin et al. (2011); however, the 
significance of the current study was to review how consumption of energy drinks in typical 
doses (1/2 to 1 can; 70 mg or 140 mg) might potentially affect cycling performance. Since 
many of the world's athletes and the general population utilize caffeine, it was important to 
see how this substance affected cycling performance beyond short distances, as typically 
examined.   
Caffeine and cycling have been studied at length, looking at numerous variables 
mainly in laboratory settings, with a few studies utilizing outdoor settings. One study that 
employed laboratory protocol and outdoor road cycling looked at the differences in pedaling 
biomechanics (Bertucci, Grappe, & Groslambert, 2007).  The researchers determined that the 
mechanics of the indoor ergometer were vastly different that the typical race bike due to the 
inertia of the flywheel and outdoor factors. The true environment of cycling occurs outdoors; 
however, conducting a study outdoors introduces many factors that the researcher cannot 
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control.  Bertucci, Grappe, & Groslambert’s study (2007) compared the use of an indoor 
cycle ergometer and two outdoor conditions: uphill cycling and level ground cycling.  The 
information presented gave the researcher insight into how the mechanics and dynamics of 
the flywheel on the indoor ergometer compared and contrasted to an outdoor race bike.  For 
example, a stationary cycle ergometer creates differences that an outdoor bicycle may limit 
or have additional effects on.  Specifically, when cycling outdoors, one can utilize standing 
and full body weight in order to achieve maximal performance.  Riding indoors on a 
stationary cycle, the flywheel of the cycle keeps turning; therefore, the cyclist cannot gain 
any advantage from a potential elevation change (i.e. the downhill slope outdoors). 
Statement of Purpose 
The purpose of this study was to determine the effect that two doses of a caffeinated 
energy drink (70 mg or 140 mg), or placebo have on performance time, RPE, HR, RER and 
VO2 for a cycling bout of 10 miles.  The researcher utilized experienced, recreational, 
caffeine naïve, male cyclists, aged 18-60, for this study in order to potentially generalize the 
effects energy drinks have on similar populations of cyclists. The independent variable in this 
study is caffeine, with the dependent variables being performance time, RER, RPE, VO2, and 
HR. The literature consists of many studies that mainly review sprint testing, or shorter 
distance laboratory protocols; therefore, this study was unique because it examined the 
impact of a caffeinated energy drink (70 mg, 140 mg, and placebo) on time, RPE, RER, HR, 
and VO2 over a non-typical distance of 10 miles.  
Hypothesis 
The researcher hypothesized that the higher dose of the caffeinated energy drink (140 
mg) would elicit a significant difference in performance time, RPE, VO2, RER, and HR at a 
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given intensity when compared to the moderate dose (70 mg), and placebo.  A second 
hypothesis stated that the moderate caffeine dose (70 mg) would elicit a significant difference 
in performance time, RPE,  RER, VO2, and HR at a given intensity over the placebo; (while 
the consumption of placebo will not produce the afore mentioned results). Conversely, the 
null hypothesis stated that there would be no significant difference in performance time, 
RER, RPE, VO2, and HR for the high dose, moderate dose, or placebo trials.  
Operational Definitions          
 Caffeine can be defined as a central nervous system stimulant (Spriet & Graham, 
2013).  Caffeine can be found in many forms such as food and medicine.  The main 
function of caffeine is to produce alertness and may also aid in performance.   
 RPE is a 15-point single-item scale ranging from 6 to 20 that assesses levels of 
perceived exertion.  The scale ranges from no exertion at all (6) to maximal exertion 
(20), (Borg, 1998; See Appendix J).  
 VO2  is physiologically defined as volume of oxygen consumed, and the average, 
peak, or max can be recorded. 
 RER is defined as the respiratory exchange ratio, and represents the amount of carbon 
dioxide produced and oxygen consumed via the gases (VCO2/VO2) collected during 
exercise (See Appendix I). 
 Caffeine naïve will be defined as consumption of no more than 1-2, 5 oz. cups of 
coffee (75 mg average of caffeine per cup) per day, or 2-4, 16 oz. caffeine containing 
carbonated beverages (40 mg average per beverage) per day.   
 Abstinence from caffeine is defined as participants who do not ingest caffeinated 
substances.   
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 Experienced cyclists will be defined as having cycled (indoor and/or outdoor) 
consistently for at least one year prior to the testing.   
 Performance time is defined as time to completion of the 10 mile distance.   
 Ergogenic aid is defined often as a supplement used “to increase potential for work 
output” (Williams, 2002).  Ergogenic aids are often utilized in athletics and 
competitions to enhance aspects of performance.   
 Placebo is a product that is used to improve performance through the power of 
suggestion (McArdle, Katch, & Katch, 2000).   
Assumptions 
 An assumption made about this study was that the participants were honest in 
reporting caffeine intake and cycling experience.  Several other assumptions were made 
concerning subjects.  Specifically, subjects were:  well-rested; properly hydrated; performed 
the test to the best of their ability; abstained from caffeine for 48 hours prior to the test; and 
abstained from vigorous activity for 48 hours prior to the test.  
Limitations 
 The use of an indoor Monark cycle ergometer does not mimic typical indoor 
stationary bicycles or outdoor bicycles. Cyclists who typically perform outdoors had 
to adjust to the indoor environment.  Due to the testing being conducted during the 
winter season, the researcher understood these limitations.  
 Collecting RPE at 2 mile increments proved to be a limitation with the study, due to 
the researcher having to ask this while the rider was cycling to their full potential (i.e. 
rider confusion/exhaustion). 
 The OxyCon portable VO2 analyzer potentially inhibited the subjects’ comfort levels, 
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breathing, and general mobility.   
 The inability to control the subjects' caffeine intake, physical activity outside of 
testing sessions, and if the participants rode to their best ability limited 
generalizability. 
 The dropout rate from the study could not be controlled by the researcher. 
 Individual reactions to the energy drink substance could vary widely. 
 Fitness level of participants was not used in participant screening. 
Delimitations 
 All individuals were male. 
 All individuals were in the age range of 18-60.  
 The cycling distance chosen for the study (10 miles) was selected based on lack of 
existing research at that distance. 
 Type (energy drink) and dosage (70 mg, 140 mg, & placebo) of caffeine ingested was 
selected based on typical consumption patterns.  
Summary 
 The purpose of the study was to examine the effects of three ingested levels of 
caffeine (placebo, 70 mg caffeine, & 140 mg caffeine) via a popular energy drink on the time 
required to cycle 10 miles, RPE, RER, VO2, and HR of experienced, caffeine naïve, 
recreational, male cyclists, aged 18-60.  The benefits of this study translate to the cycling 
community by determining if these popular energy drinks had any impact on the 
aforementioned performance variables.  Since energy drinks are widely utilized by 
recreational cyclists, uncovering information with regard to cycling performance clarifies the 
usefulness of these potential ergogenic aids.  
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CHAPTER 2:  REVIEW OF LITERATURE  
The effects of caffeine have been widely studied in the cycling community, varying 
from sprint tests to minimal endurance tests.  The purpose of this literature review is to 
evaluate the effects a popular energy drink has on cycling performance.  A variety of topics 
will be discussed such as:  cycling outdoors and indoors, physiological effects of caffeine, 
caffeine use in sports and society, and ingested forms of caffeine and variations in doses.  
Cycling and caffeine has been mainly studied with shorter distances, different doses/forms of 
caffeine administered, and the environment has been primarily indoors in a laboratory 
setting.  Examining these studies and understanding what has been accomplished in the field 
will provide the gateway to further research and questions.  This literature review will 
examine numerous areas that relate to the main topic of caffeine and cycling.  As the review 
comes to a conclusion, the purpose of the researcher's own study will fill the gaps in the 
current research and highlight the need for the current study.  The purpose of the researcher's 
study was to determine how caffeine ingested in the form of an energy drink affected cycling 
performance during a 10 mile trial as measured by the variables of time, RPE, RER, HR, and 
VO2. 
Caffeine 
 Caffeine has been widely studied in a variety of ways for numerous years.  There are 
indications that it does improve athletic performance; yet, specifics as to why it may improve 
performance have not been determined.  Caffeine increases alertness, increases focus, may 
produce an increase in heart rate, and spark central nervous system activity (Spriet & 
Graham, 2013). The physiological effect of caffeine is explained in the following quote from 
an American College of Sports Medicine (ACSM) position stance:  
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“The American Alliance for Health states that there are three possible ways that 
caffeine may provide ergogenic effects.  'First, the metabolic theory suggests that 
caffeine provides improved endurance due to an increased utilization of fat as fuel 
and a sparing effect on carbohydrate utilization.  Secondly, caffeine may increase the 
calcium content of the skeletal muscle and enhance the strength of muscle 
contraction.  Lastly, caffeine  has a direct effect on the central nervous system as a 
stimulant, which can help with fatigue, increased alertness, and increased muscle 
recruitment” (Spriet & Graham, 2013). 
Caffeine can be administered in many different ways.  The most common way it can be 
ingested is orally in one's diet, via liquid or food.  There are also uncommon methods of 
administration; such as, injected or in suppository form (McDaniel, McIntire, Streitz,  
Jackson, & Gaudet, 2010).  Power output, strength, long distance, sprint trials, and varying 
intensity exercises have all employed the use of caffeine to determine the ergogenic 
properties of the drug.  Caffeine effects people differently due to the varying numbers of and 
types of adenosine receptors in the body, and there is little evidence supporting any negative 
effects with regards to performance (McDaniel, et al., 2010).   
Energy Drinks and Pre-Workout Supplements 
 Red Bull™ was introduced in Austria in 1987 exactly ten years before it arrived in the 
United States (Reissig, Strain, & Griffiths, 2009).  Energy drinks are a large part of the 
supplement industry and has grown many times over since the market first got its start 
around the time Red Bull appeared. Some consider the use of energy drinks to be detrimental 
to one's health (Reissig et al., 2009). Prevalent in todays' society, it is not hard to observe 
someone with an energy drink, or to see an ad for this type of supplement.  Reissig et al., 
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(2009) compiled a review that detailed the use, sale, types, and settings in which energy 
drinks are prevalent.  Energy drink sales increased from about 100 million dollars in 2002, to 
650 million dollars in 2006, and 12.5 billion dollars in 2013 (Reissig, et al., 2009).  The FDA 
has attempted to regulate caffeine containing beverages, by limiting caffeine to .02%, or 71 
mg per 12 fluid ounces (oz.).  Reissig and colleagues (2009) noted that drink producers 
initially agreed and complied with this ruling, but steered clear of the unenforced limitations 
soon after.  Since energy drinks do not only contain caffeine, some of their ingredients can be 
listed as herbs or natural sources that are not monitored or regulated by the FDA.  The FDA 
does not enforce the regulation of ingredients contained in energy drinks; therefore, many do 
not list the caffeine content on the can.  It is of importance to mention that over the counter 
caffeine products (100 mg of caffeine per serving), such as energy drinks, caffeine pills, and 
energy shots, have to contain a warning label that mentions the effects of caffeine, but a “500 
mg energy drink can be marketed with no such warnings and information on caffeine dose 
amount in the product” (Reissig et al., p. 7, 2009). These findings are alarming since the 
popularity of energy drinks continues to rise.  The energy drink used in the present study was 
a MONSTER™ Energy Zero Ultra.  MONSTER™ is the second most popular energy drink 
sold in the Unites States, averaging 16 ounces per can, with a mean caffeine concentration of 
10 mg/oz. of fluid (MONSTER™, 2013).   
  Ivy et al., (2009) looked at the effects of a caffeinated energy drink on cycling 
performance time.  The subjects consisted of 6 male and 6 female elite competitive cyclists 
that had previous experience with time trials, between the ages of 25 and 30 years of age.  
They completed two trials in random order, and were given either Red Bull™ or placebo 
approximately 40 minutes prior to the cycling event.  The researchers noted that caffeine 
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peaks in the blood within 30-60 minutes after ingestion.  The participants were provided 300 
ml (milliliters) of water every 20 minutes while cycling in the indoor laboratory.  The amount 
of energy drink given to the subjects was the equivalent of two cans of Red Bull™, which 
also contained other substances other than caffeine such as:  taurine, pantothenic acid, 
vitamin B6, glucoronolactone, carbohydrates, niacin, and 10 micrograms of vitamin B12.  
The present study’s energy drink (MONSTER™) contained all of the above listed ingredients 
as well, but in different amounts. Energy drinks almost always contain other substances 
including the caffeine dose that may have an effect on someone's performance. Subjects 
performed a practice trial before the experimental trials began; also their VO2
 
max and 
maximal workload (Wmax) was determined.  Subjects VO2 max was established when VO2 
plateaued while exercise intensity increased and RER was greater than 1.10.  It is of interest 
to note that the participants did not know how long that they had been cycling; all time 
recording devices were out of sight.  Subjects were instructed to pedal at or above 90 
revolutions per minute (rpm).  The time-trial was conducted to replicate cycling for one hour 
at a workload of 70% of the subject’s specific Wmax.  The participants were instructed to keep 
a training log for 48 hours prior to the time trials and were told to keep the same dietary 
intake before their second trial.  Caffeine ingestion was instructed to be kept stable.  The 
subjects fasted for a 12 hour period prior to meeting at the laboratory for the treatment trials.  
Rate of perceived exertion was analyzed using a nonparametric Kruskal-Wallis test, and time 
was analyzed using a paired t test.  The researchers found that performance improved with 
energy drink when compared with placebo (3,690 ± 64 seconds (s) vs. 3,874 ± 93 s; p < .01). 
There was no difference found in RPE.  The authors concluded that consuming a readily 
available energy drink before an event does help with performance time without altering RPE 
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in cyclists.   
 Energy drinks contain many ingredients, although caffeine is usually the most 
common.  In the world of athletics and sports, energy drinks have become prevalent in recent 
years as a performance enhancing supplement.  Del Coso et al. (2012) studied the effects of 
two different doses of energy drink on muscle performance.  The researchers’ purpose was to 
evaluate the effects of a 1 mg or 3 mg dose of caffeine per kilogram of body weight on 
performance in upper body and lower body power-load testing.  The order was randomized 
and the participants included nine men and three women.  Participants had not been involved 
in resistance training for the prior three months and had no injuries or smoking history.  They 
were also light caffeine users, approximately 60 mg per day, or one cup of coffee. The 
subjects' 1 repetition maximum (1RM) was taken for the half-squat and bench-press 
exercises.  Each participant was involved in three separate test sessions consuming 1 mg/kg 
body weight, 3 mg/kg, or placebo, 60 minutes prior to testing. The focus of the study was 
unique; researching muscle strength and power in relation to consumption of energy drinks.  
Resting metabolic rate (RMR), HR, and blood pressure were measured 60 minutes after the 
caffeine substances were ingested, along with execution of the half-squat and bench press 
exercises.  Loads from 10% to 100% of their 1RM were performed using a rotator encoder.  
It is important to note that a phone survey was conducted the morning after the trials asking 
questions regarding sleep quality, nervousness, gastrointestinal problems and other 
discomforts that could occur with an energy drink supplement.  A one-way repeated measures 
ANOVA was used for the variables of HR, RMR, and blood pressure. A two-way repeated 
measures ANOVA was used with the variables of power-load and force-velocity to study the 
differences in the caffeine doses.  The researchers found that both doses of caffeine increased 
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blood pressure and HR in the subjects (p < .05).  The 3 mg/kg dose of caffeine in the energy 
drink substance showed an increase in the amount of power produced in both the half squat 
and bench press exercises (p < .05).  Del Coso et al. (2012) noted that the 1 mg/kg did not 
produce significant difference in the power load of the subjects, but that the greater dose did 
in fact produce greater power with the loads from 30% to 100% of their 1RM.  The authors 
discussed that the greater dose is needed to improve upper body and lower body power and 
strength.   
 Energy drinks are one of the supplements used in sports that may contain high 
amounts of caffeine; however, there are other supplements and substances that athletes use to 
aid in performance.  One of these is commonly known as a 'pre-workout' supplement.  ‘Pre-
workout’ is usually a type of powder substance that can be mixed with water or most types of 
sports drinks.  This substance is usually distributed by the scoop and there are warning labels 
not to exceed one to two scoops of the product.  Most pre-workout powders contain high 
amounts of caffeine and also many other ingredients as well.  Smith, Fukuda, Kendall, and 
Stout (2010) researched a pre-workout substance that also contained creatine, and amino 
acids.  The purpose of the study was to determine the effects this supplement had on aerobic 
and anaerobic running performance over a three week training program.  The type of training 
conducted was high-intensity interval training (HIIT). The study utilized a random design, 
with a placebo control.  The subjects consisted of 24 moderately trained athletes that either 
were given the treatment (n = 13) or placebo (n = 11).  The pre-workout supplement utilized 
was Game Time™ (Corr-Jensen Laboratories Inc.) that consisted of 18 g of powder, 40 kcals, 
whey protein, cordyceps, creatine, ginseng, citrulline, and caffeine.  The placebo only 
contained the powder and maltodextrin.  The supplements were ingested roughly 30 minutes 
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prior to the testing sessions.  The HIIT program consisted of three days per week, for three 
weeks, with testing before and after the training sessions. Maximum VO2 tests were 
conducted during the familiarization week of testing, along with timed runs to exhaustion. 
The HIIT training sessions consisted of sprints on a treadmill following intervals of rest, 
three times per week. The authors did find overall significance (p < .05) in the treatment 
group. There were some individual responses that showed an increase in VO2 max in the 
placebo group. The other ingredients in the pre-workout may have led to the increases in VO2 
max, but the authors could not pinpoint these factors (Smith, et al., 2010). 
Physiological Effects of Caffeine   
 Caffeine elicits different responses in each individual, and this is due to many factors. 
Body mass, history of usage, type and dose ingested, and timing all impact the response 
caffeine produces. Astorino, et al. (2012) researched the repeatability of caffeine's ergogenic 
effects on cycling performance.  A test-retest design was employed, with nine endurance-
trained male cyclists, participating in five separate laboratory sessions.  Practice tests were 
taken on days one and two, with actual trials on days three through five. One hour before 
testing, each subject ingested 5 mg/kg caffeine or placebo substance. The time trials 
consisted of 10 km after a 10 minute warm-up period. The subjects were informed of RPE 
and how the scale is utilized, and were instructed to ride to the best of their abilities to 
perform the trials. The participants also completed 24 hour nutrient logs pre exercise, and 
were instructed to abstain from caffeine for 48 hours prior to each session.  Caffeine was 
shown to significantly increase performance time (p = .02), when compared to placebo. The 
repeatability across the three performance sessions showed improvements of 1.6% an 1.9% 
in time, respectively.  These results indicated that there was not much improvement reported 
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in performance with caffeine usage, hinting of a repeatability issue with the results. The 
authors concluded that individualizing the tests by keeping the finalized data separate, would 
help control for differences in physiological responses to caffeine (by kg of body weight), 
and report the individual data points in the future instead of grouping all subjects together in 
aggregate.  Post-hoc tests can allow for determining which subject could have shown 
significance between trials and doses. 
 Jackman, Wendling, Friars, and Graham (1996) examined the metabolic, 
catecholamine, and endurance responses to caffeine during brief intense exercise.  
Researching the possible effects caffeine has on muscle metabolism was the primary focus of 
this study. Fourteen subjects ingested either placebo or caffeine (6 mg/kg) and cycled for two 
minutes, rested for six, cycled for two, rested for six, and then cycled to exhaustion.  Eight of 
the participants had muscle and venous blood samples taken pre and post exercise session.  
The caffeine substance showed an increase in endurance (4.12 ± .36 for placebo and 4.93 ± 
0.6 min for caffeine).  Muscle lactate was significantly increased in conjunction with caffeine 
in the last bout to exhaustion, resulting in the conclusion that caffeine consumption was 
effective in bouts of activity lasting less than six minutes.  
  Caffeine was believed to dehydrate individuals due its' diuretic effects on the 
body.  Only extreme levels of caffeine intake, upwards of 600 mg, were associated with 
dehydration.  However, even with the minimal diuretic effects, this only increases an 
individual’s fluid intake over time, lessening the occurrence of dehydration to occur.  Low to 
moderate doses of 38 to 400 mg per day were found to improve mood, sleep, hydration 
levels, and brain function, with a reduced occurrence for negative effects (Ruxton, 2008). 
Caffeine affects humans in a variety of ways.  It can produce alertness, wakefulness, a 
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sense of energy, and focus.  It may also produce anxiety, jitters, restlessness, raised heart rate 
and blood pressure, and a sense of paranoia in some.  Assessing one's own tolerance is 
advised before ingesting a large dose of caffeine (Seifert, et al., 2011).  Healthy people can 
tolerate caffeine in moderate amounts, but the heavy doses have been shown to cause health 
problems.  These problems can range from seizures, paranoia and panic attacks, to strokes 
and even sudden death.  Other adverse reactions could include:  irritability, anxiety, insomnia, 
upset stomach, tachycardia, vomiting, abdominal pain, cerebral edema, and paralysis.  Those 
that take medications, or are already diagnosed with heart disease or thyroid disease, are at a 
higher risk for these events.  It is important to note that manufacturers are not required to list 
the amount of caffeine on a beverage, such as an energy drink.  Therefore, whatever amount 
may be listed could potentially vary.  The United States poison control centers do not 
specifically record the number of overdoses on energy drinks because these are usually 
reported as caffeine or other substance exposure (Seifert, et al., 2011).  “In healthy adults, a 
caffeine intake of </= 400 mg/day is considered safe; acute clinical toxicity begins at 1 gram 
(g), and 5 to 10 g can be lethal” (Seifert, et al., 2011).  
Dosage and Dosage Timing  
 The British Nutrition Foundation compiled a review of studies examining caffeine 
and how it impacts mood, cognitive function, performance, and hydration (Ruxton, 2008).  
Fifteen years of studies consisting of varying caffeine dosages were reviewed in order to 
determine if a higher or lower dose would provide the greatest impact.  A high caffeine intake 
can lead to sleep problems, anxiety, digestive problems, and irritability.  Ruxton (2008) noted 
that most caffeine ingested in the United Kingdom, 45 mg per person per day on average, is 
from tea.  Most studies reviewed included doses of caffeine ranging from 37.5 mg to 450 mg.  
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“Caffeine is believed to impact mood and performance by inhibiting the binding of both 
adenosine and benzodiazepine receptor ligands to brain membranes” (Ruxton, 2008).  
Caffeine alters brain chemistry, and may manifest in the physicality of a person.  Tolerance to 
caffeine is different in each person, and should be respected.  Caffeine was noted to improve 
and restore cognitive function in sleep deprived subjects with a dose of 84 to 600 mg taken as 
a single bolus (dose) (Ruxton, 2008).   
Liguori et al., (1997) studied the differences in the caffeine effects of coffee, cola, and 
capsules, when absorbed by the human body.  Caffeine is readily available in many sources, 
and it is important to understand the doses and potential effects it can have on performance.  
It is a common belief that caffeine levels in coffee have a greater effect than those of colas, 
while both substances contain caffeine, the dose is very different.  Coffee (brewed, black) 
contains a caffeine dose of 102 mg/6 oz., whereas cola has 36 mg/12 oz.  These researchers 
studied the salivary concentrations of individuals post caffeine consumption, using the 
vehicles of cola, coffee, and capsule (placebo).  The capsule was utilized to serve as the 
control method. The subjects consisted of 13 volunteers, 8 men and 5 women.  They were 
asked a series of questions pertaining to caffeine history, average dosage per day and types of 
caffeine ingested, and smoking and alcohol history.  Exclusion criteria included anyone who 
had more than one alcoholic beverage per day, or someone with a chemical or drug 
dependency problem.  Subjects were also excluded if trying to alter their caffeine intake, 
such as, adjusting their daily totals, or on a restricted calorie diet.  The researchers added 200 
mg caffeine to either the coffee or cola, which increased the dosage totals to 400 mg.  Coffee, 
cola, or capsule was distributed at random to the participants on a Monday, Wednesday, and 
Friday, over a two week period.  Each session lasted approximately four hours and subjects 
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were allowed to read, write, listen to music, or converse; however, they were not allowed to 
talk about the substances and how they were feeling.  The researchers stayed in the room to 
make sure the protocol was followed.  Each subject provided a saliva sample, and completed 
a mood questionnaire and a behavior checklist.  There were no significant differences (p > 
.05) found between coffee and cola as a caffeine absorption vehicle, in time to peak, or post 
consumption.  The saliva samples showed that 400 mg caffeine of either coffee or cola 
peaked within 35-45 minutes after ingestion.  The differences in caffeine sources and the 
vehicles in which they were disbursed were shown to not impact the final outcomes of the 
trial. 
Doses of caffeine can range from the extremely high (10 mg/kg) to relatively low (1-3 
mg/kg) in research studies.  Jenkins, Trilk, Singhal, O'Connor, and Cureton (2008) examined 
the effects of low doses of caffeine on cycling performance.  The doses utilized were 1, 2, 
and 3 mg/kg of caffeine per kilogram of body weight.  Performance was measured by RPE 
on 13 subjects with experience in cycling.  A stationary ergometer was used in a laboratory 
setting.  Subjects performed 15 minutes of cycling at their respective 80% VO2 peak, 
recovered actively for four minutes, then cycled a 15 minute performance piece (all-out for 
the duration of the test). Rating of perceived exertion was obtained every three minutes, and 




 minute. When compared with the placebo 
group, caffeine doses of 2 and 3 mg/kg raised performance by 4% (p = .02) and 3% (p = 
.077) respectively.  No effects were shown on RPE during the event. The authors concluded 
that individual responses need to be studied to determine the individuality of the drug 
interactions and ergogenic properties. 
 Many studies deliver an acute dose of caffeine before an activity to determine 
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caffeine's effects on performance.  It is ideal to recruit participants who are low habitual 
caffeine users in order to avoid having tolerance to or history of caffeine ingestion becoming 
a negative factor (Del Coso et al., 2012).  Irwin et al. (2011) conducted a study to determine 
if a withdrawal period of caffeine before the acute dose would elicit a greater response in 
performance.  Forty-eight hours is the typical withdrawal period from caffeine and the 
authors of this study decided to utilize a four day period to determine the impact of a 
controlled withdrawal.  Twelve male cyclists and triathletes were recruited for the study that 
reported a caffeine use of 240 ± 162 mg/day. Peak VO2 and peak power output were tested 
before the actual testing procedures.  Subjects reported to the laboratory a total of seven 
times for pre-testing, two experimental trials, and four testing sessions. There was several 
treatment conditions paired at random to produce responses such as: placebo vs. placebo, 
placebo vs. caffeine, caffeine vs. placebo, and caffeine vs. caffeine. For 4 days prior to the 
testing period, subjects were given treatment depending on which category the researchers 
placed them in.  These randomized groups were designed in order to elicit uncontrolled 
responses from the cyclists. The pre-test caffeine was a 3 mg/kg of caffeine, whereas the day 
of test caffeine dose was 6 mg/kg (given 90 minutes before testing). Results showed that 
acute effects of caffeine occurred regardless of the pre-test treatment; the caffeine vs. placebo 
group had a 3.6% difference when compared to the caffeine vs. caffeine group (p = .002, 
Effect Size (ES) = 0.46).  There was a 3.0% difference in the placebo vs. placebo and placebo 
vs. caffeine groups (p = .021, ES= 0.40). Twenty-one of the twenty-four trials were faster 
with the acute dose of caffeine; independent of the pre-trial treatment. The researchers 
concluded that a controlled withdrawal period from caffeine did not elicit greater responses 
in the cyclists, but that the acute dose did improve the work completed (1040.85 ± 74 kJ 
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average).  The habitual use of caffeine by the subjects is speculated to have had an effect on 
the responses collected. 
When designing a study that involves a substance/treatment, it is important to 
examine all of the aspects of that variable.  Caffeine is widely consumed by athletes and non-
athletes alike.  Determining when to distribute the substance is critical to elicit certain types 
of responses.  Bell and McLellan (2002) noted that caffeine has a half-life of 4-6 hours, 
which means that a higher dose of caffeine would potentially stay in the body for longer 
periods of time. Most research studies conducted give the dose about one hour prior to the 
testing session to elicit the greatest response from caffeine.  The purpose of the study (Bell & 
McLellan, 2002) was to see if the duration of caffeine's ergogenic effect would elicit a 
response in users vs. nonusers.  Twenty-one subjects were recruited (13 caffeine users and 8 
nonusers), consisting of 15 male and 6 female. Prior to testing, their VO2 max was measured 
via a stationary cycle ergometer in a laboratory setting.  They reported to the laboratory on 
six separate occasions and completed a ride at 80% of their maximal oxygen consumption 
after consuming either placebo or a caffeinated dose of 5 mg/kg body weight.  The subjects 
completed these tests one time per week after the placebo or caffeine dose, at 1, 3, or 6 hours 
post consumption. For the subjects that abstained from caffeine, exercise times were (for the 
1, 3, & 6 hours post consumption) 32.7 ± 8.4, 32.1 ± 8.6, & 31.7 ± 12.0 min in order of 
treatment distribution. The placebo values consisted of 24.2 ±6.4, 25.8 ± 9.0, and 23.2 ± 7.1 
min. For the subjects that habitually ingested caffeine, the values were (at 1, 3, and 6 hours 
post ingestion): 27.4 ± 7.2, 28.1 ± 7.8, and 24.5 ±7.6 min.  Only the exercise times at 1 and 3 
hours post consumption were significantly greater than the similar placebo trials of 23.3 ± 
6.5, 23.2 ± 7.1, and 23.5 ±5.7 minutes. The authors concluded that the ergogenic effects of 
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caffeine were more prevalent in the nonusers due to the absence of a tolerance or build-up in 
their systems. 
Placebo Effect, Heart Rate, & Respiratory Exchange Ratio  
The placebo effect can occur through the power of suggestion via the mind. The 
authors Beedie, Stuart, Coleman and Foad (2006) studied the effects that placebo, when 
believed to be caffeine, had on cycling performance.  Six male cyclists participated in two 10 
km time trials to gather a baseline, and three actual time trials. The subjects were told they 
would be given a placebo, 4.5 mg/kg or 9.0 mg/kg dose before their cycling trial.  They were 
all given only placebo to determine how this affected their performance.  All subjects were 
interviewed and said they had experienced caffeine related symptoms.  The group that 
believed they had taken the 9.0 mg/kg dose increased their performance by 3.1% more power 
than baseline.  The group that was told they were taking a 4.5 mg/kg dose also improved 
their performance by 1.3% more power. The placebo group even had a 1.4% decrease in 
performance because they were told they would be ingesting only placebo. All results 
reported used a significance level of p < .05.  Few studies have been conducted merely on the 
placebo effect, and future studies to further quantify this effect are needed.  The researchers 
saw a placebo effect, both positive and negative, in the well-trained group of cyclists. 
Madsen, Klavs, MacLean, Kiens and Christensen (1996), examined the effects of 
glucose supplementation, glucose with branched chain amino acids (BCAAs) 
supplementation, and placebo on 9, male, trained cyclists performing a 100 km endurance 
bout.  These sessions were separated by 7 days; after 3-5 familiarization trials. The subjects 
were instructed to perform the bouts to the best of their ability, much like the present 
researcher’s guidelines.  The subjects performed the trials on their own bicycles in a lab, and 
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the bicycles were placed on a trainer that securely held the back frame of the bike. Heart rate, 
expired gas samples, and blood samples were taken at the 10, 30, 60, 90, 120, and 150 
minute marks, as well as at the end of the 100 km distance.  The data was analyzed by a two-
way analysis of variance for repeated measures. Significance (p < .05) and all data were 
described via the means. Significant differences were not observed for the performance time 
variable; however, it is vital to state that the three times were:  Glucose (Trial G) only (160.1 
+/- 4.1 min), BCAA + Glucose (Trial B) (159.8 +/- 3.7 min), and in Placebo (Trial P) only 
(159.8 +/- 3.7 min).  The subjects were randomly assigned a dose, and the researchers did not 
know what their subjects were ingesting either (double-blind, random assignment). The 
researchers also found in Trial G, a mean VO2 in l/min of 3.31 +/- 0.06; Trial B, 3.50 +/- 0.06 
l/min; and Trial P, 3.39+/- 0.04 l/min. Heart rate means were reported as: Trial G, 154 +/- 3; 
Trial B, 154 +/- 3; and Trial P, 151 +/- 2 beats per minute. Respiratory exchange ratio values 
were reported at minute 120 of the trials as: Trial G, 0.862 +/-0.012; Trial B, 0.867 +/- 0.008; 
and Trial P, 0.846 +/- 0.013. The researchers reported that while RER did not show a 
significant difference (p = .08), that the RER did drop more dramatically in the placebo 
group.  
Caffeine in Sports 
 Caffeine is widely used by the public, and it is frequently used in sports.  Athletes 
take a risk when utilizing substances that have a questionable effect on performance.  
Sokmen et al., (2008) compiled a review of considerations that athletes need to take into 
account when consuming caffeinated substances.  Caffeine is found naturally in coffee beans, 
tea, and cocoa beans, and is the world's most consumed pharmacologic and psychoactive 
product (Sokmen et al., 2008).  The central nervous system is greatly affected by caffeine.  
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The hormones, metabolism, muscular function, cardiovascular function, lung functions, and 
renal function during activity and homeostasis are affected.  There are many positive and 
negative reports relating to caffeine usage, the athletes and coaches must do their research 
and be smart in regards to consumption and dosage.  An athlete's size, gender, prior history of 
caffeine usage, and age all must be taken into consideration.  “The stimulation of the 
sympathetic nervous system by caffeine acts on multiple metabolic pathways to improve 
endurance performance” (Sokmen et al., p. 983, 2008).  Studies of the past hinted that 
carbohydrate stores were saved and fat was utilized for energy and this was how performance 
increased.  However, recently it has surfaced that caffeine may delay central nervous system 
fatigue, and have a hypo-analgesic effect on the musculature of the body, therefore also 
decreasing RPE. The researchers also noted that normal doses of caffeine do not actually 
dehydrate someone, or cause poor athletic performance (due to hydrating with fluids and the 
maintenance of stable electrolyte balance).  This is a common misconception among 
competitive athletics and athletes (Sokmen et al., 2008).  “The half-life of caffeine is 
approximately 4 to 6 hours, and plasma concentration has been shown to peak in 30-60 
minutes” (Sokmen et al., p. 983, 2008).  This suggests that caffeine should be ingested 
roughly 60 minutes prior to an endurance event.  This ties into the methods design of the 
present study since the participants consumed the caffeine substance 30 minutes prior to the 
timed trial; having the substance peak at 60 minutes, ensured that the subjects experienced a 
peak roughly midway (5 miles) through their ride. 
 Caffeinated substances and their effects on humans, specifically during performance, 
justify the inclusion of caffeine in the category of performance enhancing substances.  Many 
of these substances are not regulated by any governing body, so athletes have full access to 
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taking and using these products.   Supplementation can only aid the athlete so much; this is 
when actual nutrition makes the greatest difference in performance.  Fueling the body with 
the appropriate nutritional intake is vital in performing to one's best ability.   
Nutritional Intake and Cycling Environment 
 Saris, van Erp-Baart, Brouns, Westerterp, and ten Hoor, (1989) studied the nutritional 
intake of cyclists during the Tour de France.  The purpose of the study was to determine if the 
cyclists were gaining adequate nutrition for the amount of energy that was being expended.  
Five male cyclists were studied over the 22 day period of the Tour de France, which consists 
of 4000 km with up to 2700 m in altitude changes. This race only allows for one day of rest 
during the three week period of distance cycling.  This endurance race is one of the most 
grueling courses known to man.  Comparable contests include century runs (100 miles 
distance), and swimming the English Channel.  Data collection included daily food logs, and 
their energy expenditure (EE) was estimated during this time by their sleeping and resting 
durations, and their cycling bouts each day.  These cyclists had participated in the Tour at 
least three times prior to this race. A nutritionist noted that energy drinks made up a 
substantial part of the cyclists’ daily calorie logs. The average EE from carbohydrate intake 
consisted of 62% and fat was 23%. The cyclists took concentrated vitamin/mineral 
supplements to aid in their lack of nutrients from food sources. The average intake was 
surprisingly balanced, researchers noted.  The average EE of the cyclists was 6100 
kilocalories.  The authors noted that the major source of fat intake, 27.3%, came from sweet 
cakes, and that given a better food source the cyclists may have performed better.  Liquid 
carbohydrate sources seemed to aid in their performance as well.  Nutritional intake is just as 
important as energy drinks and supplements that an athlete may ingest.  The top athletes in 
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their arena of sport often follow their nutrition to extreme levels in order to gain the most 
benefit from their bodies for performance. 
 Cycling, whether indoors, outdoors, laboratory setting, or even off-road, are all 
different types of environments.  Bertucci, Grappe, and Groslambert (2007) conducted a 
study that reviewed these.  They wanted to determine if cycling in a laboratory or outdoors 
required different biomechanics. The variables also studied were crank torque profile and 
perceived exertion in either setting.  The true environment of cycling is outdoors with a 
variety of terrain and weather issues.  The authors utilized seven male cyclists that 
participated in seven different tests to determine these differences. The cadences of the 
cyclists were one factor, ranging from 60 rpm, to 100 rpm. The researchers noted that at the 
same cadences, cycling indoors elicits a greater perceived exertion due to stiffness and 
dampening of the flywheel, as opposed to an outdoor race bicycle (Bertucci et al., 2007). It is 
important to note that the wind velocity was ranging from 0-1.4 meters per second across 
trials, as measured by an anemometer.  Taking weather into account is important because the 
researchers noted this still did not affect the perceived exertion as much as the indoor setting. 
A Wilcoxon test was used to determine the statistical significance in the RPE variables 
between conditions.  The RPE in the laboratory environment was significantly higher (p < 
.05) when compared with the outdoor environments. There have not been many studies 
conducted in off-road cycling performance and how the differences relate to the cyclists 
effort.  This study was reviewed due to the outdoor, off-road nature of the study.  Reviewing 
indoor and outdoor cycling protocols is necessary to understand the research and how it 
translates to actual cycling.  
 Impellizeri, Rampinini, Sassi, Mognoni, and Marcora (2005) conducted a study with 
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13 competitive off-road male cyclists to determine the outdoor effect on performance.  Peak 
VO2, peak power output, lactate threshold, and onset of blood lactate accumulation were all 
calculated one week prior to the race day. Time to completion of course and ranking within 
the group determined correlation between the physiological variables to body mass. The race 
consisted of 31 km with 1260 m in altitude climb, and the temperature was 25° Celsius.  The 
course was competition level, and was closely monitored.  The researchers found that the 
measured variables, when held standard and normalized to body mass, did correlate 
significantly to competition time. The best 6 riders and the worst 6 riders had average times 
from 5453 s ± 312 to 6139 s ± 267, respectively, with an effect size of 1.52.  The authors 
concluded that maximal and submaximal aerobic fitness testing is an accurate way to 
measure off-road cyclists, but that the norms should be standardized to body mass of an 
athlete. Off-road performance and power output greatly relate to one another, and these 
variables should be further studied to determine if aerobic testing for these athletes can be 
done in a more accurate way. 
 The environment in which one performs a cycling experiment greatly influences the 
outcome and the results of the test.  Ganio et al. (2011) studied the effects caffeine produces 
on leg muscle pain during exercise in hot and cool environments.  Exercising in the heat can 
require more energy; independent of the intensity level at which the activity is performed.  
The heat causes different physiological responses than the cold, and these need to be 
accounted for when performing and designing research studies. Ganio et al. (2011) recruited 
11 male cyclists that participated in four different sessions to determine the effects caffeine 
may produce in different environments. The study was randomized and employed a double-
blind strategy.  The subjects cycled for 90 minutes at 65 ± 7% of their VO2 max, immediately 
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followed by a 15 minute performance ride.  The participants ingested 3 mg/kg of caffeine or 
placebo one hour prior to exercise, and 45 minutes after beginning the session.  The 
researchers measured central, local, and overall perceived exertion.  Throughout the warmer 
(33° C) performance period, all levels of RPE were significantly greater (p < .05), 
independent of the caffeine substance. Caffeine did not reduce pain in the 12° C group (p = 
.542), but in the 33° C groups’ caffeine dose did reduce pain by 27% (p = .032).  Although 
there are apparent differences identified, caffeine improved performance regardless of the 
temperature in which the study was conducted. The authors concluded that caffeine did 
reduce leg pain overall in warmer and cooler environments, but that in warmer environments 
it aided in producing the same hypo analgesic effect that other researchers had found. 
Intake Regulations/Restrictions  
 Spriet and Graham (2012) wrote an article on the current use and status of caffeine for 
the ACSM.  The ACSM is a governing body that promotes fitness and health, and is a 
network for professionals and students.  The article discusses a previously stated topic, 
referring to caffeine being the most widely used substance in the world, and its use 
continuing to grow in the population.  Athletes must be consciously aware of caffeine’s 
effects when ingesting this substance, and ethical and moral questions often arise when they 
do so.  The FDA has attempted to regulate caffeine containing beverages, by limiting caffeine 
to .02%, or 71 mg (milligrams) per 12 fluid oz.  Certain levels of caffeine in the urine are a 
marker for doping, or misuse of the product.  The International Olympic Committee (IOC) 
states that a level of 12 micrograms or more in the urine meets the doping status criteria, 
whereas the National Collegiate Athletic Association (NCAA) has a level of 15 micrograms.  
Caffeine has been on and off the banned list of substances for many years.  Chronic users 
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who train with caffeine can simply abstain before their race/event and the testing will not 
show that they are over the limit, even if they use the substance prior to the race.  It is 
projected that abstaining from caffeine before taking a dose will elicit greater benefits than 
chronic use. (Spriet & Graham, 2012). 
Oxygen Consumption (VO2) & Performance Time 
  Oxygen consumption (VO2) can be measured for many different purposes and can be 
beneficial in determining the physiological component that make a study unique.  Peak, 
maximal, and average oxygen consumption can all be utilized to serve a specific purpose.  
Hogervorst, et al., (2008) utilized caffeine to determine if physical performance was 
improved for an exhaustive exercise bout.  Their caffeine substance was delivered by way of 
a carbohydrate containing energy bar, to 24 male participants.  The well-trained cyclists 
ingested the bar, containing 45 g of carbohydrate and 100 mg of caffeine, or 300 milliliters 
(mL) of placebo beverage, or a carbohydrate bar with equivalent calories that did not contain 
caffeine. The groups were randomly selected, and participated in three separate trials. The 
duration of exercise completed was 2.5 hours at 60% of the cyclists’ respective VO2 max.  
Further supplementation (whichever group they were in) was given at the 55 and 115 minute 
mark, and 200 mL of water was administered at the beginning and every 20 minutes of 
exercise.  The researchers analyzed the data via repeated-measures ANOVA.  The 
participants self-reported an average daily caffeine dose of 170 mg/day (this is important to 
note for future studies utilizing caffeine).  There were no significant differences in mean 
heart rate reported between trials (p = .14).  However, there was a significant difference 
found with maximum heart rate between the caffeine dosed bar and the placebo beverage (p 
= .001).  The authors did not find significance in the RPE of subjects between treatments. 
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Caffeine did show the most significance in the time to exhaustion variable (p < .001).  The 
time to exhaustion in the caffeine and carbohydrate bar groups were significantly longer than 
the placebo beverage only group (p = .031).  Caffeine improved the time to exhaustion by 
354 seconds, a 27% improvement.  The researchers did not find differences in the relative 
intensity (% VO2 max) between trials (p = .15).  The authors concluded that there was a 
definite increase in concentration, faster response speed, and caffeine did produce significant 
effects on the variables of time to exhaustion, and maximal heart rates between trials. 
 Wiles, Coleman, Tegerdine, and Swaine (2006) conducted a study examining the 
effects of caffeine on performance time, speed and power.  Their study was conducted in a 
laboratory setting consisting of a one kilometer (0.65 mi) time-trial.  Wiles et al. (2006) 
utilized 8 male subjects that were placed in three groups: placebo, control, or 5 mg/kg body 
weight dosage of caffeine.  There were three separate testing events determining peak power, 
performance time, and speed.  The authors found that caffeine did in fact improve 
performance time; caffeine vs. placebo, vs. control (71.1 s ± 2.0 s vs. 73.4 s ± 2.3 s vs. 73.3 s 
± 2.7 s) p =0.02.  This change represented 3.1% improvement in time versus the placebo 
group (p = .0005).  Peak power was shown to increase from 864 ±107 watts in the placebo 
group, and 830 ± 87 watts in the control group, to the final 940 ± 83 watts in the caffeine 
dose group (p = .027).  The researchers found that these results were consistent with the 
literature, with the shorter duration time-trial cycling tests. 
Rating of Perceived Exertion 
 Doherty and Smith (2005) compiled a meta-analysis over caffeine ingestion and RPE 
during and after exercise.  Twenty-one studies were reviewed with 109 effect sizes that met 
the inclusion criteria. The researchers found 44 studies that measured the effects of caffeine 
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on RPE.  Subjects abstained from caffeine between 12 and 168 hours, with a median time of 
24 hours, and the time between dosage and activity ranged from 30 to 360 min (median of 60 
min).  The caffeine doses ranged from 4-10 mg/kg with a median of 6.0 mg/kg.  The authors 
found a 6% reduction in RPE when caffeine usage was employed. It was concluded that 
caffeine does in fact alter RPE levels, but the specifics as to why have not yet been 
determined. 
 Doherty, Smith, Hughes, and Davison (2004) utilized 11 male cyclists and employed 
the pre-loaded cycle protocol to determine the effects of caffeine. The subjects cycled for two 
minutes at 100% of their maximal power (determined pre-trials), followed by one minute of 
all-out effort. The cyclists participated in a ramp-test to determine their max power output, 
and then completed two other cycling trials. The caffeine load prescribed was 5 mg/kg or 
placebo in a randomized, double-blind procedure.  It is important to note that the cyclists 
used their own bikes for these procedures. The 6-20 Borg scale for RPE measurements was 
employed for this study. The RPE was lower in the caffeine group by 1 RPE point at 30, 60, 
and 120 s during the pre-load test (p < .05).  The average power-output during the all-out 
effort section of the test was also higher following the caffeine usage when compared with 
placebo [794 ± 164 vs. 750 ± 163 W; (p = .05)].  The authors concluded that cycling 
performance at higher intensities can be improved following a moderate caffeine ingestion 
which may be related to a lowering of RPE. “On the other hand, the performance element of 
a test in which athletes set their own pace closely mimics the physiological and perceptual 
responses the athletes experience in competition and thus confers a large measure of 
ecological validity” (Doherty et al., 2004). Real world experiences that can be closely 
mimicked in laboratory setting often translate to having a high external validity.  RPE is 
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subjective and can be difficult to use in a research study due to the variety of reasons.  The 
best way to control for this is to thoroughly explain Borg's RPE scale in order to enhance the 
subjects' understanding of the variable and methods of measurement. 
 The International Association for the Study of Pain (1979) defined pain as “an 
unpleasant sensory and emotional experience associated with actual or potential tissue 
damage, or described in terms of such damage” (Gliottoni, Meyers, Arngrimsson, Broglio, & 
Motl, p. 150, 2009).  Twenty-four college aged males were recruited for this study to 
determine the effects of caffeine on quadriceps muscle pain during acute cycling events in 
low vs. high caffeine users. The subjects’ caffeine use was self-reported and they were placed 
in two groups. Low caffeine use consisted of </= to 100 mg/day; n = 12, and high caffeine 
users >/= to 400 mg/day; n = 12.  The muscle-pain in the quadriceps was measured using a 
scale from 0-10 that contains 12 categories. An incremental exercise test using a laboratory 
cycle ergometer was performed to determine VO2 peak.  There was one day of pre-
experimental testing and two days of experimental testing.  The subjects were required to 
record nutritional intake for seven days prior to the testing sessions. On testing days, subjects 
ingested placebo or 5 mg/kg caffeine, 60 min. prior to performing 30 min of cycling at 80% 
of their VO2 peak.  Every 5 minutes the subjects recorded their muscle pain rating during 
both sessions of work. The average pain ratings in the caffeine and the placebo group were 
3.00 ± 1.6 and 3.8 ± 1.7 respectively.  The authors found that the caffeine contributed to a 
lower perception in leg muscle pain, in both the low and high users of caffeine. They also 
noted that this was not what they expected to find.  Their research hypothesis stated that an 
acute dose of caffeine in habitual users would not decrease leg pain as much as in low users 
of caffeine.  They found that an acute dose did in fact lower leg pain in both groups. Caffeine 
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has been shown to have a hypo analgesic effect on the musculature of the legs, therefore 
limiting the perceived pain felt after ingestion during exercise. 
 Another study that highlights the perception of leg muscle pain during cycling 
exercise after caffeine ingestion was conducted by Motl, O'Connor, and Dishman (2003).  
Sixteen, low-caffeine consuming, college-aged males participated in the study which 
involved a high dose of caffeine (10 mg/kg) or placebo being distributed 60 minutes prior to 
testing. The subjects were non-smokers and of average body weight.  Thirty minutes of 
moderate cycling (60% of VO2 peak), was performed after the caffeine or placebo was 
consumed.  The groups were randomly assigned the treatment, and the perceptions of leg 
muscle pain were significantly reduced after the high dose of caffeine was consumed (p = 
.01; p < .05). This study also employed the category scale from 0-10 that had verbal cues 
with each level.  “Pain ratings assessed by the category scale were significantly correlated (r 
= .79-.94) with concurrent pain intensity assessed by a standard 10 cm visual analogue scale 
with verbal anchors of 'no pain' and 'worst possible pain'” (Motl et al., p. 317, 2003).   
This study also discussed the hypo analgesic effects of caffeine on the body.  This could be 
due to the effect on the central nervous system.  Authors noted that future studies may 
examine the hypo-analgesic effect of caffeine at greater exercise intensities that provide for 
higher leg muscle pain. Caffeine history of the subjects can greatly alter the expected elicited 
response; therefore future studies need to accommodate this problem and explore greater 
intensities with caffeine being the main variable. 
 The last study to be examined was conducted by Yeomans, Ripley, Davies, Rusted, 
and Rogers (2002).  The researchers examined the effects of caffeine on performance and 
mood, and these variables were plotted against the level of caffeine abstinence.  Designing a 
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study requires giving the treatment at precisely the right time to subjects, in this case the 
caffeine dose, while also noting the participants’ caffeine history and usage. Using habitual 
caffeine consumers that may or may not experience a withdrawal period prior to testing is a 
good idea to control for accurate elicited responses, but recruiting caffeine abstainers would 
be ideal for a research study. Thirty moderate (self-reported) caffeine consumers (19 women 
and 11 men) were employed for this study; they were given a drink with 0, 1, or 2 mg/kg 
caffeine at their breakfast followed one hour later by another drink with either 0 or 1 mg/kg 
caffeine.  Mood and performance measures were taken 45 minutes post ingestion of each 
substance, using the Bond-Lader mood scales, and the rapid visual information processing 
(RVIP) task. The Bond-Lader mood scales produce three mood levels: mental alertness, 
calmness, and contentedness.  Reaction time from the RVIP task was significantly affected by 
the breakfast load of caffeine; F(2,23) = 4.49, p < .05).  The reaction time of the participants 
given placebo at breakfast had an average of 521.9 ± 15.1 ms, 45 minutes after the dose 
given, which was significantly different (p < .05) than those given the 1 mg/kg (475.6 ± 15.0 
ms) or 2 mg/kg (460.1 ± 15.2 ms). “In line with many previous studies, caffeine decreases 
reaction time and increased response accuracy on the performance task as well as increasing 
rated mental alertness” (Yeomans et al., p. 247, 2002).  The authors concluded that caffeine 
did increase response acuity and decrease reaction time, which could prove to be beneficial 
in athletes in their competitive season.   
Summary 
 To reiterate the importance of this review, many variables were examined to further 
justify the need for new research.  Delving into the current research and justifying aspects of 
the present study provide for validation of the topic.   Reissig et al. (2009) studied the 
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prevalence of energy drinks and the usage of them in sports performance.  Ivy et al. (2009) 
looked at the effects of a caffeinated energy drink on cycling performance time.  Wiles et al. 
(2006) conducted a study examining the effects of caffeine on performance time, speed and 
power. Hogervorst et al., (2008), produced a study that examined caffeine in the form of an 
energy bar, being ingested before a 2.5 hour exhaustive cycling bout.  They found that there 
were significance differences between maximal heart rates, and time to exhaustion between 
groups.  Further research needs to be conducted as to why this physiologically occurs.  
Maximal heart rates and improved time to exhaustion may not necessarily mean that the 
cardiovascular system is working at a greater efficiency. These studies further indicate that a 
study on the effects a popular energy drink may have on cycling performance time, VO2, 
RER, HR, and RPE, over a distance of 10 miles, is much needed in the research community. 
These results can be utilized by the recreational cycling population, with a potential for 
experimentation in the competitive circuit as well.  
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CHAPTER THREE:  METHODOLOGY 
Participants 
 
 Institutional Review Board (IRB) approval was obtained before any recruitment 
began (Appendix A).  Participants were recruited from the University of Central Oklahoma 
(UCO) via flyers (Appendix G), and a UCO email blast sent to male students, faculty, and 
staff.  Flyers were posted in the Kinesiology and Health Studies Department, and placed at 
the front desk of the Wellness Center.  The participants were well informed prior to any 
testing and assured that their participation was voluntary for the duration of the study.  The 
inclusion criterion included:  subject’s age, sex, cycling history, caffeine usage, and health 
status.  Caffeine naïve (1-2 5 oz. cups of coffee, or 2-4 12 oz. sodas per day) (Spriet & 
Graham, 2013) or abstainers of caffeine were required for this study.  Subjects were males 
between 18 and 60 years of age, with experience in cycling, and currently participating 
recreationally.  Experience was justified as having cycled (indoors or outdoors) for at least 
one year.  Subjects were classified as “apparently healthy”.  Participants were required to fill 
out a Physical Activity Readiness Questionnaire (PAR-Q) asking qualification questions to 
determine their risk-classification (Appendix C).  An informed consent was also explained to 
and signed by the subject (Appendix E).  There was a pre-testing meeting to cover all of the 
details of the study to inform the subjects of the step-by-step process of the study, and to 
secure their informed consent.  Subjects unable to attend the pre-test meeting scheduled 
meetings individually to secure pre-screening materials.  A Questionnaire for Proposed 
Subjects and Participation Information Sheet (Appendix B) was also filled out by the 
subjects.  Subjects were given a comprehensive list containing common caffeinated foods 
and beverages at the pre-test meeting (Appendix H) since they were required to abstain from 
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caffeine for 48 hours prior to each trial.  The exclusion criteria involved injury, disease, 
females, under the age of 18, over the age of 60, and insufficient experience with indoor or 
outdoor cycling for at least one year. 
 The sample size was estimated from research by Wiles, Coleman, Tegerdine and 
Swaine (2006) that examined the effects of caffeine ingestion on performance time.  
Descriptive statistics were run reporting mean, standard deviation, range, and sample size per 
variable. A 1-factor repeated measures analysis of variance was utilized to statistically 
analyze the data once it was collected. To estimate sample size, Mean 1 – Mean 2 divided by 
the Standard Deviation of control led to a .81 Cohen's D, effect size (r = .81).  By using the 
statistical power of the t-test for one sample or two related samples, a desired power of .80 
estimated the sample size of 14 in order to produce statistical significance.   
The researcher recruited 16 subjects to participate in the cycling trials.  This was a 
manageable sample size and the researcher did not report any difficulties in recruitment, 
scheduling, or communication. Attrition rates were not a problem due to the three separate 
trials being conducted on the UCO campus in the Kinesiology Lab in the Wellness Center.  
Subjects were then randomly assigned in order of testing; the moderate dosage (8oz. 
MONSTER™ Zero Ultra Energy Drink- 70 mg of caffeine, AND 8 oz. of placebo beverage), 
the high dosage (16 oz. of MONSTER™ Zero Ultra Energy Drink- 140 mg caffeine) and the 
control (placebo trial).  The control trials’ placebo consisted of 16oz. of carbonated flavored 
water.  The volume of liquid was kept the same for each trial, independent of contents.  The 







The participants were instructed to abstain from caffeine for 48 hours prior to the 
proposed testing time at the UCO Wellness Center Lab.  Each subject was included in three 
separate trials. The participants wore comfortable clothing of their choice, and were provided 
with one bottle of water after each cycling bout for hydration purposes. The caffeine 
substance, provided by the researcher, was administered using MONSTER™ Energy Zero 
Ultra Drink.  This drink contains 140 mg of caffeine per 16 oz. can, and 70 mg per 8 oz. A 
stop watch was used by the researcher to collect completion time and the cycle ergometer 
contained a digital face plate that recorded distance.  The subjects were instructed to cycle 
the 10 mile distance as efficiently as possible; they were given minimal coaching cues from 
the researcher.  The pace and resistance was self-selected to mimic the subject's typical 
exercise bout.  However, the resistance setting the subject chose during the first trial was 
duplicated for the remaining second and third trial. Rating of Perceived Exertion was 
obtained at 2 mile checkpoints by the researcher via verbal feedback from the subject.  The 6-
20 Borg scale was utilized (Appendix J). Volume of oxygen consumption and RER were 
analyzed using the OxyCon Mobile portable gas analyzer system. Volume of oxygen 
consumption, HR, and RER were recorded at 2 mile check points throughout the trial. 
Resting heart rate was recorded at pre- and post-trial.  The temperature and humidity of the 
room were recorded from a monitor on the wall.  The subjects completed a 5 minute warm-
up, then the 10 mile bout, and then performed an active cool-down of 5 minutes on the cycle 
ergometers.  The subjects then sat in a chair for 2-3 minutes, and then their recovery heart 
rate was obtained. This was repeated 3 separate times per subject, with one week between 





 The tests were conducted at the UCO Wellness Center, in the Kinesiology Lab.   The 
subjects were recruited via flyers at UCO, and UCO email blasts.  All of these methods were 
approved beforehand by the Internal Review Board (IRB) at UCO (Appendix A).  Subjects 
were male, recreational cyclists between the ages of 18 and 60, with experience in cycling 
having cycled (indoor/outdoor) for at least one year prior to the testing.  Experience was 
determined by a questionnaire with a series of questions relating to fitness level and 
type/duration of exercises completed during a 7 day period (Appendix B).   The questionnaire 
contained questions regarding the participants’ current caffeine consumption on a typical 
day/week, and the types/doses of caffeine ingested.   Caffeine naïve was defined as 1-2, 5 oz. 
cups of coffee, or 2-4, 12 oz. carbon containing caffeinated beverages per day (200 mg or 
less) (Spriet & Graham, 2013). Each dose was randomly distributed per subjects’ trial, and 
the protocol was repeated for three separate trials, 7 days apart, with different doses 
measuring the same variables. The sample size consisted of 16 participants. The tests were 
conducted with one participant at a time in the laboratory, and the subject self-selecting their 
own music (if chosen), pace, and resistance.  
The rules, design, risks, dangers, protocol and purpose of the study was explained 
thoroughly. The participants were informed before the testing trials began (Appendix E), and 
they were instructed to ask questions to ensure compliance and full understanding.  They 
arrived at the testing location having abstained from caffeine, and vigorous exercise for at 
least 48 hours prior to the testing. Each dose (140 mg, placebo, & 70 mg) was given to the 
subject 20 minutes prior to the start of the trials.  Participants did not know before-hand 




Participants wore the OxyCon Mobile analyzer harnessed to their back, and the face 
mask was placed securely upon their face. This recorded their VO2, HR (via a POLAR heart 
rate strap) and RER throughout the entire trial in 2 mile increments. The subjects were 
instructed to cover the distance at a self-selected pace and resistance, and to cycle to the best 
of their ability. The participant RPE was measured every 2 miles throughout the 10 mile trial.  
Subjects were allowed to self-select resistance, pace, and music (if they desired). These 
procedures were repeated for each test session (3 sessions). It was explained to the subjects 
that as they were approaching each 2 mile increment, they would be asked their RPE level, 
and this would be recorded.  RPE was explained to the participants before the trials began, 
and was collected via verbal feedback.  The Borg scale of perceived exertion (RPE) was 
utilized (Borg, 1998):  The RPE scale is a 15-point single-item scale ranging from 6 to 20 
that assesses levels of perceived exertion (Appendix J).  The scale ranges from no exertion at 
all (at 6) to maximal exertion (at 20).  The levels of 6-20 often correlate with the person’s 
heart rate; for example, an RPE of 14 might equate to a heart rate of 140 bpm. Subjects were 
instructed to abstain from caffeine in all forms for 48 hours prior to the cycling trial.    
Design and Analysis 
The data were summarized by variable, dose, and distance using summary statistics 
(sample size, mean, standard deviation, and range) and line graphs (mean and standard 
deviation).  There were 16 participants in the study but the analysis for each variable 
included only those participants who had complete data (sample size range 13-16).  A one-
factor analysis of variance, repeated measure design, was used to determine significant 
differences between the means at distances within each dose and between the means of doses 
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within each distance.  For a significant difference, the multiple comparison test, Least 
Squared Difference, was used to determine which means were significantly different.  The 
format for reporting significant differences uses “-“; for example, 2-4,6 indicates that the 
mean at 2 miles is significantly different than the means at 4 and 6 miles.  In addition to p-
values, the effect size, partial eta-squared, was reported as a measure of the proportion of 











CHAPTER FOUR:  RESULTS 
The purpose of this study was to determine the effect that two doses of the caffeinated 
energy drink (70 mg or 140 mg), or placebo (control) have on time to completion, RPE, HR, 
RER and VO2 for a cycling bout of 10 miles.  Resting Heart Rate (RHR) was also analyzed 
at pre- and post-trial for subjects. There were no outliers reported in the current data set, 
however, there were missing data observations which resulted in varied sample sizes. 
Data Analysis 
The data were summarized by variable, dose, and distance using summary statistics 
(sample size, mean, standard deviation, and range) and line graphs (mean and standard 
deviation).  There were 16 participants in the study but the analysis for each variable 
included only those participants who had complete data (sample size range 13-16).  A one-
factor analysis of variance, repeated measure design, was used to determine significant 
differences between the means at distances within each dose and between the means of doses 
within each distance.  For a significant difference, the multiple comparison test, Least 
Squared Difference, was used to determine which means were significantly different.  The 
format for reporting significant differences uses “-“; for example, 2-4,6 indicates that the 
mean at 2 miles is significantly different than the means at 4 and 6 miles.  In addition to p-
values, the effect size, partial eta-squared, is reported as a measure of the proportion of 
variability within a given variable that is explained by either dose or distance. 
Data in this study included RPE, VO2, RER, HR, and Time to completion.  These 
variables were measured at three doses (control, 70 mg, and 140 mg).  Rating of perceived 
exertion, VO2, RER, and HR were measured at five distances (2, 4, 6, 8, and 10 miles).  
Resting HR was measured pre- and post-trial and time to completion was measured once. 
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Data was analyzed using SPSS 21.0 (SPSS Inc., Chicago, IL) and Excel.  P-values 
less than .05 were considered significant.  Traditional cut points for effect size are:  small, 0 – 
0.3; medium, 0.3 – 0.5; and large, greater than 0.5. 
Results 
Summary statistics for demographics are shown in Table 1.  The average age was 30.0 
and ranged from 23 to 51 years.   Biking experience ranged from1 to 20 years (average 4.97 
years) and was inversely correlated with body mass index (BMI) (r=-0.690, p = .003).  The 
largest variability between subjects was caffeine consumption which ranged from 0 (2 
subjects) to 800 mg.  None of the demographic variables were significantly correlated with 
completion times of the three doses.  The average height was 71.3 inches with a range of 66.5 
to 76.0 inches. Subjects had an average weight of 85.7 kg, with a range of 75.0 kg to 97.7 kg.  
The mean daily consumption of caffeine per subject was 168.6 mg.  
Results of the statistical analyses of the differences between means for the doses at 
each distance and the distances within each dose are shown in Tables 2-7.  For the variables 
RPE, VO2, and HR the means between distances (2, 4, 6, 8, & 10 miles) were significantly 
different (p < .001) within each dose.  For RER, only for the control group were the means 
significantly different (p = .009) between 2-4-6-8-10 miles.  For the variables RPE, RER, and 
HR the means between doses were not significantly different.  For VO2, only at 2 miles were 
the Control means between doses significantly different (p = .033).  Effect size was highly 
correlated with the p-values (r=-0.789, p < .001) for all variables. 
RPE 
 Sample size consisted of all 16 subjects.  The means at each distance within each of 
the doses increased linearly (Table 2; Figure 1).  With the exception of 2 miles, means for the 
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control trial were slightly higher than for 70 mg dose and 140 mg dose.  For the control trial 
the means increased from 10.4 at 2 miles to 14.4 at 10 miles.  The 70 mg dose means 
increased from 10.3 at 2 miles to 14.1 at 10 miles.  Similarly, the 140 mg dose means 
increased from 10.6 at 2 miles to 14.1 at 10 miles 
VO2 
             For VO2 (n = 14), the means at each distance for 70 mg were lower than those for the 
control and 140 mg.  At 2 miles, the mean for 70 mg was significantly lower (p = .033) and at 
6 miles, it was approaching significance (p = .065).  The means for 70 mg increased linearly 
from 2 to 10 miles whereas the means for the control and 140 mg peaked slightly at 6 miles 
and again at 10 miles (Figure 2).  Similar patterns for significant differences between means 
occurred within the control and 140 mg doses; means for 2 and 4 miles were significantly 
different than means for 6, 8, and 10 miles (Table 3; Figure 2).  
RER  
Sample size consisted of 14 subjects.  The means increased linearly only for the 
control trial for the 2-6 mile checkpoints, but a decrease in means was seen from the 6 mile 
point to the 8 and then to the 10 mile mark (Table 4; Figure 3).  The 140 mg and 70 mg trials 
both saw a series of increases and decreases in means throughout the trial. RER for the 
control group peaked at 6 miles and was significant (p = .009) between miles 2-6, 4-6, 6-8, 
and 6-10.   
HR  
Sample size consisted of 15 participants.  The means also increased linearly across 
distance for each dose.  Significance was found (p < .001) for all means within doses except 
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the mile 6-8 means in the control group (Table 5; Figure 4).  Although not significant, mean 
for 140 mg group were slightly higher than 70 mg and control groups.  
TIME 
Sample size consisted of 16 subjects.  There was no statistical significance reported (p 
= .237) between doses (Table 6; Figure 5). However, the fastest mean time occurred in the 
control trial and the slowest mean times were observed with the 140 mg dose group.   
Resting Heart Rate  
Sample size consisted of 13 subjects.  RHR was analyzed to determine changes pre- 
and post-trial and between groups. The range was greatest at pre-trial with the control group 
(54-90 bpm), and at post-trial with the 140 mg group (60-120 bpm). Significance between 
doses was not found (p = .547); however, within doses significance was found (p = .001 for 














CHAPTER FIVE:  DISCUSSION 
 The purpose of this study was to determine the effect of two doses of a caffeinated 
energy drink (70 mg or 140 mg), or placebo had on performance time, RPE, HR, RER and 
VO2 for a cycling bout of 10 miles. The researcher hypothesized that the higher dose of the 
caffeinated energy drink (140 mg) would elicit a significant difference in performance time, 
RPE, VO2, RER, and HR at a given intensity; when compared to the moderate dose (70 mg), 
and placebo.  A second hypothesis stated that the moderate caffeine dose (70 mg) would elicit 
a significant difference in performance time, RPE,  RER, VO2, and HR at a given intensity; 
while the consumption of placebo will not produce the afore mentioned results. Conversely, 
the null hypothesis stated that there would be no significant difference in performance time, 
RER, RPE, VO2, and HR for the high, moderate, or placebo group.  
 Results from this study showed that an energy drink delivered in three different doses 
did not produce any performance enhancing benefits, and the null hypothesis was accepted.  
However, there were some noticeable trends in the data and significance was found for 
certain variables and distance markers in the trials. Although there were not any significant 
results found related to the research question, there was still meaningful data revealed in the 
results of this study.  
Recreational cyclists and a popular energy drink were used to explore the potential 
performance enhancing effects of the caffeinated energy substance.  The average cup of 
coffee contains 100-120 mg of caffeine; therefore reaching the heavy dose would only take 
about 4 cups of coffee (Spriet & Graham, 2013).  The present study utilized three doses:  140 
mg, 70 mg, and a placebo (control) substance.  Due to unrefined study protocol in the 
beginning of data collection, the researcher cannot say that the doses were truly randomized. 
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Madsen et al., 1996, conducted a study with similar characteristics used in the current 
study:  similar variables, trials, endurance protocol, and variable interaction with placebo. 
Significant differences were not observed for the performance time variable; however, it is 
vital to state that the placebo response is reflected via the variable Trial times:  Glucose (Trial 
G) only (160.1 +/- 4.1 min), BCAA + Glucose (Trial B) (159.8 +/- 3.7 min), and in Placebo 
(Trial P) only (159.8 +/- 3.7 min). The placebo group, while not significant, yielded the 
fastest mean times. The present study found the fastest 10 mile performance to completion 
times in the placebo trial (26.32 minutes).  The 140 mg dose elicited a mean time of 27.17 
minutes and the 70 mg dose elicited a mean time of 26.91 minutes. The researcher believes 
this primarily happened due to subject familiarization of the study protocol.  By the third trial 
the subjects saw a decrease in performance time regardless of dosage ingested.   
Ivy et al., (2009), utilized 6 female and 6 male elite, competitive cyclists and 
examined the variables of RPE and performance time. Rate of perceived exertion was 
analyzed using a nonparametric Kruskal-Wallis test, and time was analyzed using a paired t 
test.  The researchers found that performance improved with energy drink when compared 
with placebo (3,690 ± 64 seconds (s) vs. 3,874 ± 93 s (p < .01). There was no difference 
found in RPE between trials.  The current study found significance within each dose, but not 
between the dose groups. This refers to the means being significantly different from different 
points in the trial (for each dose), for example, from mile 2 to mile 8 in the placebo group, 
the RPE went from 10.4 to 13.8.  This is to be expected with physical activity though; as time 
progresses and expenditure and exertion increase, RPE typically increases. 
The present study found at 2 miles, the mean VO2 for 70 mg was significantly lower 
(p = .033) than 140 mg and placebo, and at 6 miles, it was approaching significance  
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(p = .065). Volume of oxygen consumption also reported a large effect size of 0.517 for the 
70 mg dose which shows a high trend.  The researcher noted that perhaps a slight dose of 
caffeine (70 mg) as opposed to a larger dose (140 mg) may elicit an improved VO2 at earlier 
distances at lower intensities.  Similar patterns for significant differences between means 
(increasing linearly with distance) occurred within the control and 140 mg doses (p < .001); 
means for 2 and 4 miles were significantly different than means for 6, 8, and 10 miles (Table 
3).  Hogervorst, et al., (2008) utilized caffeine to determine if physical performance (HR and 
VO2) was improved for an exhaustive exercise bout.  The duration of exercise completed was 
2.5 hours at 60% of the cyclists’ respective VO2 max. The researchers did not find differences 
in the relative intensity (% VO2 max) between trials (p = .15); similar to the VO2 results of 
the current study (Table 3).   
The present study did not achieve statistical significance between doses for the HR 
variable either, but within trials significance was found (p < .001), except the placebo doses 
between miles 6 and 8.  The effect size per dose (placebo: r= 0.662, 70 mg: r= 0.713, and 
140 mg: r= 0.759) show an increasing HR trend independent of the dose.  Hogervorst, et al., 
(2008) utilized twenty-four subjects, compared to the present study’s sample size of 16.  
Average daily caffeine consumption of Hogervorst, et al., (2008) subjects consisted of 170 
mg; whereas, the present study’s participants reported an average daily consumption of 
168.62 mg. There were no significant differences in mean HR reported between trials (p = 
.14). In the present study HR was expected to increase as distance increased as the trend 
indicated (Figure 4).   
Respiratory exchange ratio was reported by Ivy et al., 2009, from minutes 5-10, 30-
35, and 40-45, but was only utilized to establish VO2 max only during the last three minutes 
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of the cycling bout.  Respiratory exchange ratio was used to establish a VO2 max when it 
reached a value greater than 1.10 (Appendix I).  In the present study RER was measured 
throughout the 10 mile cycling trials, but was recorded only at the 2, 4, 6, 8, and 10 mile 
points.  Respiratory exchange ratio was found significantly different (p = .009) for the control 
group trial (placebo), but not for the 140 mg and 70 mg doses.  During the control trials RER 
was shown to increase up until mile 6 then decrease to mile 10 (Figure 3).  This could be due 
to the riders expelling their greatest effort during the beginning of the trial, in the absence of 
caffeine, and then having to taper off in order to finish the 10 miles efficiently (see Table 4).  
The 140 mg and 70 mg dosed trials both saw an increase and decrease in the means across 
the 10 mile distance (Figure 3), which also shows an increase in effort and a decrease in 
effort (i.e. potential pacing).  Respiratory exchange ratio will physiologically increase and 
decrease as effort and energy levels fluctuate. 
Strengths 
One of the main strength of this study is the lab equipment the researcher had access 
to.  The OxyCon Mobile unit, manufactured by Care Fusion™, which UCO possesses, is not 
a common piece of equipment.  It is a portable, highly expensive, gas analyzer, and can be 
worn by the subject with ease. The researcher was trained on the equipment, and felt 
comfortable with her knowledge base in moving forward with the study.   
The researcher also experienced minor scheduling difficulties and only had one 
participant who was unable to complete all three trials.  There were no unexpected issues 
with subjects, and all subjects were on time for their data collection appointments.  The 
researcher only had 3 potential subjects report to the initial informational meeting, but 
received an overwhelming email response from the mass email that was distributed to male 
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students, faculty, and staff at UCO.  
Another observed strength of the study was the willingness of the participants to push 
themselves to expel their best effort each time they performed a 10 mile cycling trial. They 
also seemed quite competitive with themselves and made many comments about their 
performance on previous trials compared to the current trial they were completing.  The 
subjects all possessed an interest in the study and also how their performance for each trial 
varied.  Questions were asked of the researcher reflecting critical thinking regarding the 
study protocol and components that the general population one would assume not ask.   
Limitations 
Multiple limitations exist in this study.  A small sample size (n = 16) could be viewed 
as a limitation for this study, since the researcher was examining and analyzing many 
variables.  However, Doherty, Smith, Hughes, and Davison (2004) only utilized 11 male 
cyclists and Wiles et al. (2006) utilized 8 male subjects.  Many cycling studies do not 
incorporate large sample sizes.  This could be due to many factors such as: exertion required 
of the protocol, time commitments, having to abstain from caffeine in certain instances, 
abstaining from vigorous activity before a trial, and few subjects meeting the inclusion 
criteria for studies. 
Missing data for certain variables led to different sample sizes. Rating of perceived 
exertion (n = 16), VO2 (n = 14), RER (n = 14), HR (n = 15), Time (n = 16), and RHR (n = 
13) for a range of 13-16 participants.  For VO2, RER, and HR, there was missing data 
collected due to the mobile gas analyzer malfunctioning in some way.  In these few instances, 
the researcher simply moved on with data collection and recorded what available data she 
could.  Resting heart rate had a sample size of 13 due to the researcher not allowing for time 
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to collect this variable at the beginning and/or end of 3 out of the 47 trials.  
One subject expressed increasing his carbohydrates the night before one of the trials, 
which the researcher could speculate on a performance enhancement due to that.  Also, the 
overall nutrition, hydration, and rest levels of the subjects the researcher did not control.  The 
varying fitness levels of the participants could have also led to the present results, and 
honesty about abstaining from caffeine could have also been an issue.  The stationary bicycle 
does not mimic a rode type or mountain style bicycle, and it was expressed by the subjects 
the discomfort they were feeling due to the seat design. 
Another limitation observed could be the length of the protocol.  The researcher 
initially asked subjects to allow for 60-90 minutes for each trial, but the process was found to 
only take between 50-65 minutes from start to finish.  This is still quite a time commitment to 
ask of subjects, keeping in mind it was repeated for three separate trials.  The researcher 
experienced overall pleasant attitudes from subjects, and no complaints were made of the 
time commitment.  
The researcher had two participants that had a unilateral tibial amputation.  These 
gentlemen were avid athletes and this physical disability was not perceived by the researcher 
to negatively impact the study.  They were able to strap both of their feet to the pedals on the 
stationary ergometer just like the other participants.  
Future Directions 
 The researcher notes that utilizing a larger dose of caffeine would be a new direction 
to take this study that may elicit significance results between dosage groups.  The doses 
utilized in the present study, placebo, 70 mg or 140 mg caffeine, would amount to .09 – 1.86 
mg/kg body weight in an average weight rider of 75 kg.  This is not a very large dose 
58 
 
compared to the use of caffeine at 6 mg/kg utilized by Irwin et al., (2011), but was selected to 
represent typical doses.   
Utilizing competitive cyclists such as Ivy et al., (2009), could potentially produce 
more consistent results in future trials.  The present study emphasized recreational riders and 
the typical dose consumed before a recreational cycling bout.  However, the subjects ranged 
from triathletes and mountain bikers, to road racers and the occasional rider.  The current 
study utilized cyclists with a range of experience consisting of one to twenty years.  Upon 
completion of this study, the researcher noted that utilizing subjects with similar backgrounds 
and experience in cycling might prove to be beneficial in the future.  Homogenous fitness 
levels (as defined by a certain VO2max), similar body composition, and the use of cycling 
shoes that clip into the bike’s pedals could enhance and provide for more accurate results.     
Familiarization trials would be an effective tool to utilize in the future.  The present 
study consisted of three separate trials, and the researcher documented that by the third trial 
(regardless of dosage) that the subjects had faster times.  This could be due to becoming 
familiar with the study protocol and knowing how the subjects could pace themselves more 
efficiently.  Astorino, Cottrell, Lozano, Aburto-Pratt, and Duhon (2012) researched the 
repeatability of caffeine's ergogenic effects on cycling performance.  A test-retest design was 
employed, with nine endurance-trained male cyclists, participating in five separate laboratory 
sessions.  Practice tests were taken on days one and two, with actual trials on days three 
through five. Caffeine was shown to significantly increase performance time (p = .02), when 
compared to placebo. The repeatability across the three performance sessions showed 
increases of 1.6% and 1.9% in time improvement, respectively.  The practice sessions, or 
familiarization trials, showed repeatable, accurate results.  
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Another recommendation for future research is to have the participants keep a 
nutritional dietary log for 48 hours prior to each testing session, and to have the subjects keep 
this pattern of intake consistent for each subsequent trial.  
Practical Applications 
Recreational cyclists that consume energy drinks in typical quantities may not be 
receiving the actual benefits they perceive to attain from the proposed ergogenic energy 
substance. The present study did not find statistical significance which translates to 
performance enhancing benefits, with a 10 mile cycling bout. These drinks are costly and if 
they are perceived to provide performance enhancing benefits then the population will 
continue to purchase and ingest them.  The researcher did find significance among certain 
variables at different points throughout the 10 mile cycling trials, for the variables RPE, VO2, 
and HR the means between distances (2, 4, 6, 8, & 10 miles) were significantly different (p < 
.001) within each group.  For RER, only for the control group were the means significantly 
different (p = .009).  For the variables RPE, RER, and HR the means between groups were 
not significantly different.  For VO2, only at 2 miles were the means between groups 
significantly different (p = .033).  Effect size was highly correlated with the p-values (r = -
0.789, p < .001).  The researcher cannot say that this type of energy substance elicits 
performance enhancing benefits for the recreational cycling population.  
Other energy substances are readily available such as:  coffee, different types of tea, 
caffeinated powders and drinks.  For recreational cyclists, there is no regulated limit on 
intake, such as the limits set by the IOC (12 micrograms (µg)/ml) and for the NCAA 
(15µg/ml) (Spriet & Graham, 2013).  One microgram equates to 0.001 milligrams.  Cyclists 
may have their own personal methods and supplements that they perceive to provide 
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performance enhancing benefits, and the researcher recommends that research be examined 
to check these protocols for safety and safe levels of supplementation. 
Conclusions  
 It can be concluded that the energy drink utilized by the researcher, delivered in 2 
different typical doses, and placebo substance, does not elicit performance enhancing benefits 
in a sample size of 16 male participants cycling 10 miles on an indoor stationary ergometer. 
The performance enhancing variables measured were:  VO2, RER, RPE, Time, and HR.  It is 
important for recreational cyclists to listen to his or her body and fuel adequately depending 
on his or her goals and consciously choose to ingest typical amounts of energy drinks for 
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Summary Statistics for Subject Demographics  
        
    Age Height Weight Caffeine Experience BMI 
  Mean 30.0 71.30 85.706 168.625 4.97 26.172 
n=16 SD 8.1 2.73 6.945 192.054 5.11 1.992 
 
Range  23-51  66.5-76 75.0-97.72 0-800 1-20 23.15-29.22 
     
Note. Age reported in years; height in inches; weight in kilograms; caffeine in milligrams, 
experience reported in years, body mass index (BMI) reported as weight in kilograms divided 











Table 2  
Summary Statistics for RPE 
         
  






(n=16)   2 4 6 8 10 Sig Diff   
  Mean 10.4 11.7 12.9 13.8 14.4 *<0.001 0.717 
CONTROL SD 2.2 1.6 1.2 1.4 1.8 ALL   
  Range 6-14 9-15 11-15 12-16 12-18     
  Mean 10.3 11.4 12.6 13.6 14.1 *<0.001 0.683 
70 mg SD 2.0 1.5 1.1 1.4 1.6 ALL   
  Range 6-13 8-14 11-15 12-16 12-17     
  Mean 10.6 11.5 12.5 13.4 14.1 *<0.001 0.681 
140 mg SD 1.7 1.4 1.5 1.5 2.1 ALL   
  Range 7-12 8-13 9-15 11-17 12-19     
  p-value 0.751 0.703 0.293 0.335 0.448 
 
  
  ES 0.019 0.023 0.079 0.070 0.052 
 
  
Note. Significant p-values are indicated with an asterisk (*).  SD = standard deviation, ES = 











Summary Statistics for VO2 
  




   p-value ES 
DOSE 
(n=14)   2 4 6 8 10 Sig Diff   
  Mean 21.65 22.10 24.81 23.88 25.05 *<0.001 0.335 
CONTROL SD 4.87 5.73 5.78 5.96 5.93 2-6,8,10;   
  Range 12.9-29.1 9.6-29.3 12.4-33 13.5-35 14.6-37.4 4-6,8,10   
  Mean 19.29 21.36 21.89 23.56 23.64 *<0.001 0.517 
70 mg SD 4.71 5.17 5.06 5.64 6.28 2-4,6,8,10;   
  Range 10.5-28.2 10.1-28.5 12.3-30.8 13.5-33 10.3-31 
4-8,10;    
6-8,10   
  Mean 21.71 22.20 24.50 24.19 25.57 *<0.001 0.355 
140 mg SD 5.78 5.71 6.51 6.98 8.00 2-6,8,10;   




   *0.033 
140-Cont,70 0.708 0.065 0.907 0.351 
 
  
  ES 0.231 0.026 0.189 0.007 0.073 
 
  
Note. Significant p-values are indicated with an asterisk (*).  SD = standard deviation, ES = 











Summary Statistics for RER 
  






(n=14)   2 4 6 8 10 
Sig 
Diff   
  Mean 1.060 1.076 1.106 1.081 1.069 *0.009 0.226 
CONTROL SD 0.067 0.058 0.068 0.075 0.079 
2-6;  
4-6;   
  Range 0.93-1.15 1-1.18 1-1.23 0.97-1.26 0.96-1.26 6-8,10   
  Mean 1.064 1.057 1.073 1.078 1.074 0.532 0.050 
70 mg SD 0.084 0.061 0.060 0.075 0.087 
 
  
  Range 0.94-1.25 0.96-1.16 0.99-1.17 0.93-1.22 0.92-1.21     
  Mean 1.061 1.076 1.089 1.074 1.084 0.466 0.065 
140 mg SD 0.063 0.049 0.058 0.064 0.081 
 
  
  Range 0.97-1.19 0.98-1.14 0.97-1.18 0.95-1.16 0.95-1.24     
  
p-
value 0.969 0.425 0.152 0.941 0.812 
 
  
  ES 0.002 0.064 0.135 0.005 0.016 
 
  
Note. Significant p-values are indicated with an asterisk (*).  SD = standard deviation, ES = 












Summary Statistics for HR 
  






(n=15)   2 4 6 8 10 Sig Diff   
  Mean 124.5 132.6 139.9 142.9 147.3 *<0.001 0.662 
CONTROL SD 16.9 19.5 22.2 24.1 23.6 
ALL 
except   
  Range 90-152 96-156 99-174 99-180 107-186 6-8   
  Mean 122.5 130.9 136.3 141.7 146.1 *<0.001 0.713 
70 mg SD 18.7 21.8 25.4 26.8 29.7 ALL   
  Range 93-147 97-158 101-169 99-173 104-180 
 
  
  Mean 124.9 133.6 139.9 145.7 153.0 *<0.001 0.759 
140 mg SD 22.0 22.1 24.9 23.5 23.0 ALL   
  Range 86-152 93-160 87-168 103-176 105-188     
  p-value 0.676 0.670 0.635 0.507 0.120 
 
  
  ES 0.028 0.028 0.032 0.047 0.141 
 
  















Summary Statistics for TIME 
  
   
Distance 
(miles) 
   
  
DOSE 
(n=15)   2 4 6 8 10     
  Mean         26.321     
CONTROL SD 




  Range         21.01-30.33     
  Mean         26.910     
70 mg SD 




  Range         19.48-32.54     
  Mean         27.173     
140 mg SD 




  Range         22.51-31.39     
  p-value 




  ES 




Note. Significant p-values are indicated with an asterisk (*).  SD = standard deviation, ES = 













   
p-value ES 
DOSE 
(n=13)   Pre       Post Sig Diff   
  Mean 72.9 
 
    86.6 *0.001 0.641 
CONTROL SD 10.9 




  Range 54-90       72-108     
  Mean 69.8 
 
    87.5 *<0.001 0.682 
70 mg SD 11.4 




  Range 54-85       66-108     
  Mean 72.5 
 
    87.2 *0.004 0.511 
140 mg SD 9.4 




  Range 58-88       60-120     
  p-value 0.547 




  ES 0.049 




Note. Significant p-values are indicated with an asterisk (*).  SD = standard deviation, ES = 
effect size.   



















CONTROL 70 mg 140 mg
 
Figure 1.  Summary Statistics for RPE shown at 2 mile increments across the 10 mile cycling 
















Figure 2.  Summary Statistics for VO2 shown at 2 mile increments across the 10 mile cycling 
















Figure 3.  Summary Statistics for RER shown at 2 mile increments across the 10 mile cycling 















Figure 4. Summary Statistics for HR shown at 2 mile increments across the 10 mile cycling 














Figure 5.  Summary Statistics for Completion Time of the 10 mile cycling trials, shown color 

















Figure 6.  Summary Statistics for Resting HR at pre- and post-trial color-coded by dose.  
Resting heart rate pre:  Control = 72.9; 70 mg = 69.8; 140 mg = 72.5 
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December 18, 2013 IRB Application #: 13196 
Proposal Title: The Impacts of a Caffeinated Energy Drink on Rating of Perceived Exertion, 
Completion Time, Heart Rate, Volume of Oxygen Consumption, and Respiratory Exchange 
Ratio During a 10-Mile Cycle Ergometer Trial.  
Type of Review: Initial-Expedited 
Investigators: 
Ms. Nicole Doyle 
Dr. Darla Fent 
Department of Kinesiology and Health Studies  
College of Education and Professional Studies 
Campus Box 189 
University of Central Oklahoma  
Edmond, OK 73034  
 
Dear Ms. Doyle and Dr. Fent: 
Re: Application for IRB Review of Research Involving Human Subjects  
We have received your materials for your application. The UCO IRB has determined that the 
above named application is APPROVED BY EXPEDITED REVIEW. The Board has 
provided expedited review under 45 CFR 46.110, for research involving no more that 
minimal risk and research category 7. 
Date of Approval: 12/18/2013 
Date of Approval Expiration: 12/17/2014 
If applicable, informed consent (and HIPAA authorization) must be obtained from subjects 
or their legally authorized representatives and documented prior to research involvement. A 
stamped, approved copy of the informed consent form will be sent to you via campus mail. 
The IRB-approved consent form and process must be used. While this project is approved for 
the period noted above, any modification to the procedures and/or consent form must be 
approved prior to incorporation into the study. A written request is needed to initiate the 
amendment process. You will be contacted in writing prior to the approval expiration to 
determine if a continuing review is needed, which must be obtained before the anniversary 
date. Notification of the completion of the project must be sent to the IRB office in writing 
and all records must be retained and available for audit for at least 3 years after the research 
has ended. 
It is the responsibility of the investigators to promptly report to the IRB any serious or 
unexpected adverse events or unanticipated problems that may be a risk to the subjects. 
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On behalf of the UCO IRB, I wish you the best of luck with your research project. If our 
office can be of any further assistance, please do not hesitate to contact us. 
Sincerely, 
Melissa Powers, Ph.D. 
Assistant to the Chair, Institutional Review Board 
Campus Box 159 
University of Central Oklahoma 
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Questionnaire for Proposed Subjects  
1. What is your age, height, and weight? 
2. What is your experience with indoor/outdoor cycling (how long have you 
participated)? 
 
3. What is your current weekly physical activity consisting of? 
 
 
4. What is your daily caffeine intake consisting of? (type and dosage; Average cup of 
coffee = 120 mg) 
 
5. Do using typical doses of caffeine produce any feelings of anxiety following intake? 
 
6. Is there any reason you could not participate in this study (perform a 10 mile cycling 
bout on an indoor stationary cycle ergometer)? 
 
Participant Information Form 
Please fill out the following contact information. 
Name: ______________________________ Age: ______ 
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UNIVERSITY OF CENTRAL OKLAHOMA  
 
INFORMED CONSENT FORM 
 
Research Project Title: The Impacts of a Caffeinated Energy Drink on Rating of  
 
Perceived Exertion, Completion Time, Heart Rate, Volume of Oxygen Consumption, and  
 
Respiratory Exchange Ratio on a 10-Mile Cycle Ergometer Trial   
 
Researcher (s): Nicole Doyle  
 
A. Purpose of this research:  The purpose of this research is to determine the 
potential effects a popular energy drink (administered in 2 doses, 70 mg and 140 mg), 
or placebo, may have on RPE, completion time, heart rate, RER and VO2; for a 
stationary, indoor cycle ergometer session of 10 miles. 
B. Procedures/treatments involved: Subjects will be instructed to abstain from 
caffeine containing substances at least 48 hours prior the trial start.  Upon arrival 
subjects will ingest their specific dose of MONSTER Ultra Zero Energy Drink of 70 
mg, 140 mg, or placebo substance.  They will wait approximately 30 minutes, 
perform a 5 minute warm-up of self-selected pace and resistance, then begin the 10 
mile cycling trial.  The subject will be wearing the OxyCon Mobile portable VO2 gas 
collection analyzer, which consists of a breathing mask and harness type backpack 
system.  Their VO2, RER, RPE, heart rate, and completion time will be recorded.  
The variables of heart rate, RER, VO2, and RPE will be recorded at 2 mile 
increments.  The subjects will be instructed to perform the 10 mile test to the best of 
their ability, with the option of listening to music.  Subjects will be provided with one, 
16.9 ounce (oz) bottle of water.  Subjects will perform a 5 minute active cool-down 
on the cycle ergometer, and then will be allowed to leave the facility after sitting for 
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approximately 10 minutes.  After signing this form you will be asked to fill out the 
Physical Activity Readiness Questionnaire (PAR-Q) that asks questions regarding 
your ability to participate in physical activity, the questionnaire for proposed subjects, 
and the participant information form required for the study.    
C. Expected length of participation: Three testing sessions that last approximately 
60-90 minutes per session.  The trials should be completed over a 3-week time frame.  
D. Potential benefits:  Knowledge of average VO2 for the 10 mile duration, and how 
caffeine in the form of a popular energy drink may affect your cycling performance 
time, VO2, RER, RPE, and heart rate.  
E. Potential risks or discomforts: Potential discomforts associated with 
participation in this study may include muscle soreness and muscle fatigue. In 
addition, caffeine related symptoms may arise, such as:  jitters, anxiety, and/or a light 
to moderate headache.  By signing this form, you indicate that you understand the 
UCO is not liable for any injuries that may occur during your participation in this 
study. 
F. Medical/mental health contact information (if required): Medical assistance is 
located at The Mercy Health Clinic.  The Clinic is located on the first floor of the 
University Wellness Center and is open from 8:00-5:00, Monday through Friday; the 
telephone number is (405) 974-2317.  The University Counseling Center is located in 
the Nigh University Center, Suite 402, and is open 8:00-5:00, Monday through 
Friday.  They can be reached at (405) 974-2215. 
G. Contact information for researchers: For questions about the study or an injury 
related to the study, please contact the principal investigator. 
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 Nicole Doyle    Dr. Darla Fent 
 (918) 698-7564  (405) 974-3599 
 ndoyle@uco.edu  dfent@uco.edu  
H. Contact information for UCO IRB: For questions about your rights as a research 
participant, please contact: 
 Dr. Richard Sneed 
 (405) 974-5479 
 irb@uco.edu 
I. Explanation of confidentiality and privacy: All data collected will be labeled 
with a code number that will not be identifiable to you. Information regarding your 
participation will be kept completely confidential and stored in a locked file cabinet 
in Wantland Hall room 102.  The electronic information will be kept on a flash drive 
and kept by the primary investigator (Nicole Doyle). Both types of data will be kept 
secure for three years then destroyed.  In no way will the subject’s data be tied to their 
name.  This study may result in scientific presentations and publications; however, 
your identity will be kept confidential.    
J. Assurance of voluntary participation: Your participation is entirely voluntary for 
this study and you are free to withdraw from the study at any time without penalty.  
AFFIRMATION BY RESEARCH SUBJECT 
I hereby voluntarily agree to participate in the above listed research project and 
further understand the above listed explanations and descriptions of the research project. I 
also understand that there is no penalty for refusal to participate, and that I am free to 
withdraw my consent and participation in this project at any time without penalty. I 
acknowledge that I am at least 18 years old. I have read and fully understand this Informed 
Consent Form. I sign it freely and voluntarily. I acknowledge that a copy of this Informed 
Consent Form has been given to me to keep.  
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 Research Subject’s Name:          
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Data Collection Sheet 
Cycling Performance- Distance 10 miles  
 Date:__________ 
70 mg DOSE 
Date:__________ 
140 mg DOSE 
Date:__________ 
PLACEBO 



















































RHR    
 
Dosage: Dosage: Dosage:  
Height: Height: Height: 
Weight: Weight: Weight: 



























A Research Study for Men ages 18-60 
 
We need YOU for an exciting research study! 
 
UCO Master’s student Nicole Doyle is looking for people interested in joining this interactive 
research study! This study has been designed as part of the requirements for a Master’s 
Thesis and has been IRB approved. It is a safe, supervised study led by Nicole Doyle from 
the University of Central Oklahoma’s Department of Kinesiology and Health Studies.  This 
study will utilize a popular energy drink and explore the possible cycling performance 
enhancing benefits.  
 
 Recreational cycling experience (indoor/outdoor) >/= 1 year! 
 Energy Drink provided! 
 3 separate cycling bouts, testing performance time, heart rate, respiratory  
 exchange ratio, volume of oxygen consumption, & rating of perceived      exertion! 
 The testing is conducted at the UCO Wellness Center.  
 
Location: UCO Wellness Center, Room 125 
Days: To Be Determined 
Time: 60-90 minutes of your day, 3 separate trials!  
To learn more, come to an Informational Meeting on 
 
Date: _January 22nd, 2014_ 
Time: _5:30pm_____ 
Location: UCO Wellness Center, Room 127 
 
For more information, please plan to attend our information meeting or contact:  
Nicole Doyle, (918)698-7564, ndoyle@uco.edu 
NOTE: The cycling study is a research study being conducted by Nicole Doyle from the University of 
Central Oklahoma to determine if a popular energy drink has an effect on performance time & RPE 
for an extended indoor cycle ride. Your participation in the study may involve minimal risk. In 
addition, all participants must meet qualifications for the study in order to participate. Potential risks 













APPENDIX H:   
LIST OF COMMON CAFFEINE CONTAINING FOODS/DRINKS/MEDICATIONS 











Coffees Serving Size Caffeine (mg) 
Dunkin' Donuts Coffee with 
Turbo Shot 
large, 20 fl. oz. 436 
Starbucks Coffee venti, 20 fl. oz. 415 
Starbucks Coffee grande, 16 fl. oz. 330 
Panera Frozen Mocha 16.5 fl. oz. 267 
Starbucks Coffee tall, 12 fl. oz. 260 
Starbucks Caffè Americano grande, 16 fl. oz. 225 
Panera Coffee regular, 16.8 fl. oz. 189 
Starbucks Espresso 
Frappuccino 
venti, 24 fl. oz. 185 
Dunkin' Donuts Coffee medium, 14 fl. oz. 178 
Starbucks Caffè Mocha grande, 16 fl. oz. 175 
Starbucks Iced Coffee grande, 16 fl. oz. 165 
Maxwell House Ground 
Coffee—100% Colombian, 
Dark Roast, Master Blend, 
or Original Roast 
2 Tbs., makes 12 fl. oz. 100-160 
Dunkin' Donuts Cappuccino large, 20 fl. oz. 151 
Starbucks—Caffè Latte, 
Cappuccino, or Caramel 
Macchiato 
grande, 16 fl. oz. 150 
Starbucks Espresso doppio, 2 fl. oz. 150 
Keurig Coffee K-Cup, all 
varieties 
1 cup, makes 8 fl. oz. 75-150 
Folgers Classic Roast Instant 
Coffee 
2 tsp., makes 12 fl. oz. 148 
Starbucks Doubleshot 
Energy Coffee, can 
15 fl. oz. 146 
Starbucks Mocha 
Frappuccino 
venti, 24 fl. oz. 140 
Starbucks VIA House Blend 
Instant Coffee 
1 packet, makes 8 fl. oz. 135 
McDonald's Coffee large, 16 fl. oz. 133 
Maxwell House International 
Café, all flavors 
2⅔ Tbs., makes 12-16 fl. oz. 40-130 
Seattle's Best Coffee—Iced 
Latte or Iced Mocha, can 
9.5 fl. oz. 90 
Starbucks Frappuccino 
Coffee, bottle 
9.5 fl. oz. 90 
International Delight Iced 
Coffee 
8 fl. oz. 76 




Dunkin' Donuts, Panera, or 
Starbucks Decaf Coffee 
16 fl. oz. 15-25 
Maxwell House Decaf 
Ground Coffee 
2 Tbs., makes 12 fl. oz. 2-10 
Teas Serving Size Caffeine (mg) 
Starbucks Tazo Awake—
Brewed Tea or Tea Latte 
grande, 16 fl. oz. 135 
Starbucks Tazo Earl Grey—
Brewed Tea or Tea Latte 
grande, 16 fl. oz. 115 
Starbucks Tazo Chai Tea 
Latte 
grande, 16 fl. oz. 95 
Starbucks Tazo Green Tea 
Latte—Iced or regular 
grande, 16 fl. oz. 80 
Black tea, brewed for 3 
minutes 
8 fl. oz. 30-80 
Snapple Lemon Tea 16 fl. oz. 62 
Lipton Pure Leaf Iced Tea 18.5 fl. oz. 60 
Green tea, brewed for 3 
minutes 
8 fl. oz. 35-60 
Lipton 100% Natural Lemon 
Iced Tea, bottle 
20 fl. oz. 35 
Arizona Iced Tea, black, all 
varieties 
16 fl. oz. 30 
Nestea Unsweetened Iced Tea 
Mix 
2 tsp., makes 8 fl. oz. 20-30 
Arizona Iced Tea, green, all 
varieties 
16 fl. oz. 15 
Lipton Decaffeinated Tea—
black or green, brewed 
8 fl. oz. 5 
Herbal Tea, brewed 8 fl. oz. 0 
Soft Drinks Serving Size Caffeine (mg) 
FDA official limit for cola 
and pepper soft drinks 
12 oz. 71 (200 parts per million) 
Pepsi MAX 12 oz. 69 
Mountain Zevia (Zevia) 12 oz. 55 
Mountain Dew, regular or 
diet 
12 oz. 54 (20 oz. = 90) 
Diet Coke 12 oz. 47 (20 oz. = 78) 
Dr Pepper or Sunkist, 
regular or diet 
12 oz. 41 (20 oz. = 68) 
Pepsi 12 oz. 38 (20 oz. = 63) 




Barq's Root Beer, regular 12 oz. 23 (20 oz. = 38) 
7-Up, Fanta, Fresca, ginger 
ale, or Sprite 
12 oz. 0 
Root beer, most brands, or 
Barq's Diet Root Beer 
12 oz. 0 
Energy Drinks Serving Size Caffeine (mg) 
Jolt Energy Drink 23.5 fl. oz. 280 
Rockstar Citrus Punched 16 fl. oz. 240 
NOS Active Sports Drink 
(Coca-Cola) 
22 fl. oz. 221 
5-hour Energy 1.9 fl. oz. 208 
Full Throttle 16 fl. oz. 200 
Monster Energy 16 fl. oz. 160 
Rockstar 16 fl. oz. 160 
Venom Energy Drink (Dr 
Pepper/Seven Up Inc.) 
16 fl. oz. 160 
NOS Energy Drink (Coca-
Cola) 
16 fl. oz. 160 
AMP Energy Boost Original 
(PepsiCo) 
16 fl. oz. 142 
Mountain Dew Kick Start 16 fl. oz. 92 
Red Bull 8.4 fl. oz. 80 
V8 V-Fusion+Energy 8 fl. oz. 80 
Ocean Spray Cran-Energy 20 fl. oz. 55 
Glacéau Vitaminwater 
Energy 
20 fl. oz. 50 
Starbucks Refreshers 12 fl. oz. 50 
Caffeinated Snack 
Foods Serving Size Caffeine (mg) 
Crackheads² 1 box, 40g 600 
Crackheads Espresso Bean 
Candies, regular 
1 package, 28 pieces 200 
Wired Waffles 1 waffle 200 
Perky Jerky 1 package, 1 oz. 150 
Arma Potato Chips 1 package, 2 oz. 70 
Cracker Jack'D 1 package, 2 oz. 70 
MiO Energy, all flavors 1 squirt, ½ tsp. 60 
Crystal Light Energy ½ packet 60 
Jelly Belly Extreme Sport 
Beans 
1 package, 1 oz. 50 
Jolt Gum 1 piece 45 
Alert Gum 1 piece 40 
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Blue Diamond Almonds, 
Roasted Coffee Flavored 
1 oz. 25 
Ice Cream & Yogurt Serving Size Caffeine (mg) 
Bang!! Caffeinated Ice 
Cream 
4 fl. oz. 125 
Cold Stone Creamery Mocha 
Ice Cream 
Gotta Have It, 12 fl. oz. 52 
Starbucks Coffee Ice Cream 4 fl. oz. 45 
TCBY Coffee Frozen Yogurt large, 13.4 fl. oz. 42 
Dannon All Natural Coffee 
Lowfat Yogurt 
6 oz. 30 
Häagen-Dazs Coffee Ice 
Cream 
4 fl. oz. 29 
Stonyfield Gotta Have Java 
Nonfat Frozen Yogurt 
4 fl. oz. 28 
Starbucks Mocha 
Frappuccino Ice Cream 
4 fl. oz. 25 
Baskin Robbins Jamoca Ice 
Cream 
4 fl. oz. 20 
Dreyer's or Edy's Grand Ice 
Cream—Coffee or Espresso 
Chip 
4 fl. oz. 17 
Breyers Coffee Ice Cream 4 fl. oz. 1 
Häagen-Dazs Coffee Almond 
Crunch Snack Size Bar 
1.8 oz. 10 
Dreyer's, Edy's, or Häagen-
Dazs Chocolate Ice Cream 
4 fl. oz. less than 1 
Chocolate Candy & 
Chocolate Drinks Serving Size Caffeine (mg) 
Starbucks Hot Chocolate grande, 16 fl. oz. 25 
Hershey's Special Dark 
Chocolate Bar 
1.5 oz. 20 
Hershey's—Milk Chocolate 
Bar 
1.6 oz. 9 
Hershey's Kisses 9 pieces, 1.4 oz. 9 
Hershey's Cocoa 1 Tbs. 8 
Dove Dark Chocolate Silky 
Smooth Promises 
5 pieces, 1.4 oz. 4 
Silk Chocolate Soymilk 8 fl. oz. 4 
Hershey's Chocolate Lowfat 
Milk, bottle 
12 fl. oz. 2 
Over-The-Counter Pills Serving Size Caffeine (mg) 




NoDoz or Vivarin 1 caplet 200 
Excedrin Migraine 2 tablets 130 
Midol Complete 2 caplets 120 
Bayer Back & Body 2 caplets 65 
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Rating of Perceived Exertion Chart 
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(Borg, 1998) 
 
